Sentence,class,file
"http://dx.doi.org/10.1038/8975 9 Liu, G., M. Fiala, M.T.",OADS,/arxiv_data1/oa_pdf/df/5e/JEM_20132103.PMC4042652.pdf
"22:3595– 3606. http://dx.doi.org/10.1096/fj.08­11220 1 Mirakaj, V ., C.A.",OADS,/arxiv_data1/oa_pdf/df/5e/JEM_20132103.PMC4042652.pdf
"http://dx.doi.org/10.1164/rccm.200905 ­0717O C Mirakaj, V ., S. Brown, S. Laucher, C. Steinl, G. Klein, D. Köhler, T. Skutella, C.  Meisel, B. Brommer, P .",Non-OADS,/arxiv_data1/oa_pdf/df/5e/JEM_20132103.PMC4042652.pdf
"http://dx.doi.org/10.4049/jimmunol.100267 1 Muller, W .A.",Non-OADS,/arxiv_data1/oa_pdf/df/5e/JEM_20132103.PMC4042652.pdf
http://dx.doi.org/10.1038/labinvest   .378044 6,Non-OADS,/arxiv_data1/oa_pdf/df/5e/JEM_20132103.PMC4042652.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.coph.2004.04.00 4 Balkwill, F .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1007/s10555-006-9005- 3 Balkwill, F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"9:361– 371. http://dx.doi.org/10.1038/nrc262 8 Bettermann, K., M. Vucur, J. Haybaeck, C. Koppe, J. Janssen, F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.ccr   .2010.03.02 1 Bode, A.M., and Z. Dong.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1002/mc.2034 8 Chen, F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-11-198 2 Chen, N., M. Nomura, Q.B.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/   10.1016/j.devcel.2010.05.01 4 DiDonato, J.A., F .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi   .org/10.1182/blood-2003-01-011 4 Dybedal, I., D. Bryder, A. Fossum, L.S.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10   .1182/blood.V98.6.178 2 Egberts, J.H., V .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-   07-570 4 Feoktistova, M., P .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.molcel.2011.06.01 1 Fleischman, A.G., K.J.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10   .1182/blood-2011-04-34814 4inhibitors were added if required for 1.5 h. After inhibition, cells were stimu - lated if required for 10 min and removed from the plates and then lysed using  cell lysis buffer (Cell Signaling T echnology) supplemented with protease and  phosphatase inhibitor cocktails (Roche).",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi   .org/10.1016/j.leukres.2007.01.01 4 Maeda, S., H. Kamata, J.L.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi   .org/10.1016/j.cell.2005.04.01 4 Mantovani, A., P .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/nature0720 5 Molnár, L., T. Berki, A. Hussain, P .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1007/   BF0303265 3 Moore, R.J., D.M.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/1055 2 Naugler, W .E., and M. Karin.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi   .org/10.1016/j.gde.2008.01.02 0 Oberst, A., C.P .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/nature0985 2 Oguma, K., H. Oshima, and M. Oshima.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.2217/fon.10.1 3 Papa, S., F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/ncb109 3 Perkins, N.D. 2012.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.stem.2012.08.01 3 Sakon, S., X. Xue, M. Takekawa, T. Sasazuki, T. Okazaki, Y .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi   .org/10.1093/emboj/cdg37 9 Sakurai, H., S. Suzuki, N. Kawasaki, H. Nakano, T. Okazaki, A. Chino, T. Doi,  and I. Saiki.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1074/jbc.M30159820 0 Sakurai, T., S. Maeda, L. Chang, and M. Karin.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.2741/306 6 Shaulian, E. 2010.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j   .cellsig.2009.12.00 8 Skaug, B., X. Jiang, and Z.J.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/   10.1146/annurev.biochem.78.070907.10275 0 Stifter, G., S. Heiss, G. Gastl, A. Tzankov, and R. Stauder.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1111/j.1600-0609.2005   .00551. xGallipoli, P ., F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1182/   blood-2013-02-48560 7 Grivennikov, S.I., and M. Karin.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1136/ard.2010.14014 5 Günther, C., E. Martini, N. Wittkopf, K. Amann, B. Weigmann, H. Neumann,  M.J. Waldner, S.M.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/nature1040 0 Guzman, M.L., S.J.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1182/blood.V98.8.230 1 He, S., L. Wang, L. Miao, T. Wang, F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.cell.2009.05.02 1 Hernandez-Ilizaliturri, F .J., G. Deeb, P .L.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1002/cncr.2613 5 Hess, P ., G. Pihan, C.L.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/ng94 6 Kaiser, W .J., J.W .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/nature0985 7 Kamata, H., S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"120:649– 661. http://dx.doi.org/10.1016/j.cell.2004.12.04 1 Ke, H., R. Harris, J.L.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-292 3 Kim, Y .S., M.J. Morgan, S. Choksi, and Z.G.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/   10.1016/j.molcel.2007.04.02 1 Knight, B., G.C.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1084/jem.192.12.180 9 Kuo, H.P ., Z. Wang, D.F .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.ccr.2013.08.01 9 Li, J., D.P .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10   .1172/JCI3177 2 Lim, K.H., Y .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
http://dx.doi.org/10.1111/j.1600-065X.2012.01105.,Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1038/sj.cr.729026 2 Luedde, T., N. Beraza, V .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.ccr   .2006.12.01 6 Lv, L., P .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j.cell.2011.07.03 2 T enev, T., K. Bianchi, M. Darding, M. Broemer, C. Langlais, F .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/   10.1016/j.molcel.2011.06.00 6 Tsimberidou, A.M., and F .J.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1586/14737140.2.3   .277 Tsimberidou, A.M., E. Estey, S. Wen, S. Pierce, H. Kantarjian, M. Albitar,   and R. Kurzrock.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1002/   cncr.2378 5 Vallabhapurapu, S., and M. Karin.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"27:693– 733. http://dx.doi.org/10.1146/annurev.immunol.021908.13264 1Wang, L., F .",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1016/j   .cell.2008.03.03 6 Xiao, Y ., H. Li, J. Zhang, A. V olk, S. Zhang, W .",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1182/blood-2011-06-35944 8 Zhang, J.Y ., C.L.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1101/gad.116090 4 Zhang, J.Y ., A.E.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-06-401 7 Zhang, D.W ., J. Shao, J. Lin, N. Zhang, B.J.",Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
"http://dx.doi.org/10.1126/science.117230 8 Zhang, H., X. Zhou, T. McQuade, J. Li, F .K.",OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
http://dx.doi.org/10.1038/nature0987 8,Non-OADS,/arxiv_data1/oa_pdf/19/51/JEM_20130990.PMC4042653.pdf
Available at  http://www.wada-ama.org/Documents/ World_Anti-Doping_Program/WADP-The- Code/WADA_Anti-Doping_CODE_2009_ EN.pdf accessed 19 October 2012.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
"Available at http://www.wada-ama.org/ Documents/World_Anti-Doping_Program/ WADP-IS-Testing/2012/WADA_ IST_2012_EN.pdf, accessed 23 October  2012.",Non-OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
"Available at  http://www.wada-ama.org/Documents/ World_Anti-Doping_Program/WADP-IS- TUE/2011/WADA_ISTUE_2011_ revJanuary-2012_EN.pdf, accessed 12  November 2012.",Non-OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
Available at http://www.wada-ama.org/ Documents/Resources/Guidelines/ WADA_Guidelines_Reporting_Elevated_ TE_Ratios_2.0_EN.pdf accessed 22  November 2012.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
Available  at  http://www.wada-ama.org/ Documents/World_Anti-Doping_Program/ WADP-Prohibited-list/2012/WADA_ Prohibited_List_2012_EN.pdf accessed  24 November 2012.,Non-OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
Available at  http://www.wada-ama.org/ Documents/World_Anti-Doping_Program/ WADP-IS-Laboratories/Technical_ Documents/WADA_TD2009EPO_ Harmonization_of_Method_ Identificiation_Recombinant_ Erythropoietins_Analogues_EN.,OADS,/arxiv_data1/oa_pdf/d6/fa/JBS-31-1096037.PMC4042654.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/d7/bgu006.PMC4043246.pdf
"Supplementary material Supplementary Figures 1–3  can be found at http://carcin.oxford  journals.org/ Funding Canadian Institutes of Health Research (MOP-97836 to J.-F.B., CTP- 82942 to CRC biobank).Acknowledgements We thank E.Herring for reviewing the manuscript and technical support,  E.Tremblay for virus production and G.Bernarchez for the preparation of the  colorectal tissue samples and cDNA.",Non-OADS,/arxiv_data1/oa_pdf/82/d7/bgu006.PMC4043246.pdf
"85-23, revised 1985; http://grants1.nih.gov/grants/olaw/references/phspol.htm) and the Care and Use ofLaboratory Animals (National Research Council, 1996).",Non-OADS,/arxiv_data1/oa_pdf/13/4c/cddis2013523a.PMC4043260.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Prostasin represses ovarian tumors B-x Yan et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/13/4c/cddis2013523a.PMC4043260.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/eht387.PMC4043317.pdf
"Methods Study population and setting All adultcitizensin Nord-Trøndelag County, Norway, received a postal in- vitation to participate in the second wave of the Nord-Trøndelag HealthStudy (HUNT 2, 1995–97, http://www.ntnu.edu/hunt , last accessed 28 July 2013).",Non-OADS,/arxiv_data1/oa_pdf/67/4d/eht387.PMC4043317.pdf
"The participants ﬁlled in questionnaires (http://www.ntnu.edu/hunt/data/que , last accessed 28 July 2013) and attended a baseline clinical examination.",Non-OADS,/arxiv_data1/oa_pdf/67/4d/eht387.PMC4043317.pdf
"In this article by Sivasankar Malaichamy and colleagues ( Molecular Vision v20:341-351 ), the following corrections were made: In the results sections, page 343 and in table 4, the mutations identified in TRPM1  was corrected to be c.[857C>T];[857C>T]  p.(S286L).Molecular Vision  2014; 20:780-780 <http://www.molvis.org/molvis/v 20/780> Received 2 May 2014 | Accepted 2 June 2014 | Published 2 June 2014© 2014 Molecular Vision 780Erratum: Molecular profiling of complete congenital stationary  night blindness: A pilot study on an Indian cohort Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/9a/d5/mv-v20-780.PMC4043323.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 551–561International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  551OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S6210 4real-world characterization and differentiation   of the global Initiative for Chronic Obstructive  Lung Disease strategy classification David B Price1 Christine l Baker2 Kelly h Zou3  Victoria s higgins4 James T Bailey4 James s Pike4  1University of aberdeen, Division of  applied health sciences, aberdeen,  UK; 2Pfizer Inc, Outcomes and  evidence, global health and Value,  new York, Usa; 3Pfizer Inc, statistical  Center for Outcomes, real-World  and aggregate Data, global Innovative  Pharma Business, new York, Usa;  4adelphi real World, Macclesfield, UK Correspondence: Victoria s higgins   adelphi real World, adelphi Mill,  Bollington, Macclesfield,   Cheshire sK10  5JB, UK   email v ictoria.higgins@adelphigroup.co mBackground:  This study aimed to characterize and differentiate the Global Initiative for  Chronic Obstructive Lung Disease (GOLD) strategy  2011 cut points through the modified  Medical Research Council dyspnea scale (mMRC) and chronic obstructive pulmonary disease  (COPD) assessment test (CAT).",Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report2014_Feb07.pd f. Accessed August 22, 2013.",OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
Available from: http://webcache.googleusercontent.com/ search?q =cache:KU4nflw4a9gJ:www.ajmc.com/publications/ issue/2010/2010-06-vol16-n06/AJMC_10jun_LeonardCom410to11 + &cd=1&hl=en&ct=clnk&gl=ca.,Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
Available from: http://www.esomar.org/uploads/public/ knowledge-and-standards/codes-and-guidelines/ICCESOMAR_Code_ English_.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
Available  from: http://www.hhs.gov/ocr/privacy/hipaa/understanding/summary/ privacysummary.pdf.,OADS,/arxiv_data1/oa_pdf/57/65/copd-9-551.PMC4043424.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/65/cia-9-871.PMC4043425.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 871–878Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  871OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5754 8Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: de Matthaeis et al Running head recto: Interplay among COPD, gases, and endothelium in the elderly DOI: http://dx.doi.org/10.2147/CIA.S57548 Correspondence: Antonio greco geriatrics Unit and gerontology, geriatrics  research laboratory, Department of Medical  sciences, IrCCs Casa sollievo della sofferenza,  Cappuccini Avenue 71013, san giovanni  rotondo, Foggia, Italy T el +39 08 8241 0271 Fax +39 08 8241 0271 email a.greco@operapadrepio.i t gianluigi Mazzoccoli Division of Internal Medicine and  Chronobiology Unit, Department of  Medical sciences, I rCCs Casa sollievo  della sofferenza, Opera di Padre Pio da  Pietrelcina, Cappuccini Avenue 71013,    san giovanni rotondo, Foggia, Italy T el +39 08 8241 0255 Fax +39 08 8241 0255 email g.mazzoccoli@operapadrepio.i tAngela de Matthaeis1 Antonio greco2,* Mariangela Pia Dagostino2 giulia Paroni2 Andrea Fontana3 Manlio Vinciguerra1,4,5 gianluigi Mazzoccoli1,* Davide seripa2 gianluigi Vendemiale6 1Division of Internal Medicine   and Chronobiology Unit, 2geriatrics Unit  and gerontology, geriatrics research  laboratory, Department of Medical  sciences, 3Unit of Biostatistics, I rCCs Casa  sollievo della sofferenza, san giovanni  rotondo, Foggia, 4euro-Mediterranean  Institute of sciences and T echnology,   Palermo, Italy; 5University College london,   Institute for liver and Digestive health,   Division of Medicine, royal Free Campus,   london, UK; 6geriatrics Unit, University   of Foggia, Foggia, Italy *These authors contributed equally   to this workAbstract:  Blood acid-base imbalance has important effects on vascular reactivity, which can  be related to nitric oxide (NO) concentration and increased during hypercapnia.",Non-OADS,/arxiv_data1/oa_pdf/d6/65/cia-9-871.PMC4043425.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d6/65/cia-9-871.PMC4043425.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d6/65/cia-9-871.PMC4043425.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/46/btt-8-199.PMC4043426.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 199–205Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  199Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S5337 5Plasma membrane coenzyme Q: evidence   for a role in autism Frederick L Crane1 Hans Löw2 iris Sun1 Placido Navas3 Anna Gvozdjáková4 1Department of Biological Sciences,   Purdue University, west Lafayette,   iN, USA; 2Department of Molecular  Medicine, Karolinska institute,   Stockholm, Sweden; 3Centro  Andaluz de Biología del Desarrollo,   Universidad Pablo de Olavide,   Sevilla, Spain; 4Pharmacobiochemical  Laboratory of Third Medical  Department, Medical Faculty,   Comenius University in Bratislava,   Bratislava, Slovakia Correspondence: Anna Gvozdjáková   Comenius University in Bratislava,   Medical Department,  Pharmacobiochemical Laboratory of 3rd  Medical Department, Sasinkova 4, 811 08  Bratislava, Slovakia   Tel +421 2 59357 242   Fax +421 2 59357 242   email anna.gvozdjakova@fmed.uniba.s k    Frederick L Crane   610 Country Side Dr. Metamora,   iL 61548, illinois, USA   Tel +1 309 383 2215   Cell phone +1 309 331 5931   Email flccoq10@aol.comBackground:  The V oltage Dependent Anion Channel (VDAC) is involved in control of autism.",Non-OADS,/arxiv_data1/oa_pdf/3f/46/btt-8-199.PMC4043426.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/3f/46/btt-8-199.PMC4043426.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3f/46/btt-8-199.PMC4043426.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/cia-9-879.PMC4043427.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 879–885Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  879OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S6266 0Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Pipanmekaporn et al Running head recto: Thai version of the CAM-ICU DOI: http://dx.doi.org/10.2147/CIA.S62660 Tanyong Pipanmekaporn1 nahathai Wongpakaran2 sirirat Mueankwan3 Piyawat Dendumrongkul2 Kaweesak Chittawatanarat3 nantiya Khongpheng3 nongnut Duangsoy3 1Department of Anesthesiology,   Faculty of Medicine, Chiang Mai  University, Chiang Mai, Thailand;   2Department of Psychiatry, Faculty  of Medicine, Chiang Mai University,   Chiang Mai, Thailand; 3Division of  surgical Critical Care and Trauma,   Department of surgery, Chiang Mai  University hospital, Chiang Mai,   Thailand Correspondence: Tanyong Pipanmekaporn  Department of Anesthesiology, Faculty   of Medicine, Chiang Mai University,   110 Intawaroros rd, Tambon sriphum,  Maung District, Chiang Mai 50200,  Thailand T el +66 53 945 526 Fax +66 53 945 526 email tanyong24@gmail.co mValidity and reliability of the Thai version   of the Confusion Assessment Method for the  Intensive Care Unit (CAM-ICU) Purpose:  The purpose of this study was to determine the validity and reliability of the Thai  version of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU), when  compared to the diagnoses made by delirium experts.",Non-OADS,/arxiv_data1/oa_pdf/b7/9c/cia-9-879.PMC4043427.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b7/9c/cia-9-879.PMC4043427.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/cia-9-879.PMC4043427.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/1e/copd-9-525.PMC4043428.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 525–531International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  525OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6193 2Pulmonary adenocarcinoma mutation profile in  smokers with smoking-related interstitial fibrosis andrea Primiani1 Dora Dias-santagata1 a John Iafrate1 richard l Kradin1,2 1Pathology service, 2Pulmonary  Medicine/Critical Care Unit,   Department of Medicine,   Massachusetts general hospital   and harvard Medical school,    Boston, M a, Usa Correspondence: richard l Kradin   Pathology service, Massachusetts general  hospital, 55 Fruit street, Warren 253,  Boston, Ma 02114, Usa   Tel +1 617 726 9029   Fax +1 617 726 7474   email rkradin@partners.or gAbstract:  Cigarette smoking is an es tablished cause of lung cancer.",Non-OADS,/arxiv_data1/oa_pdf/97/1e/copd-9-525.PMC4043428.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/97/1e/copd-9-525.PMC4043428.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/1e/copd-9-525.PMC4043428.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdolescent Health, Medicine and Therapeutics 2014:5 89–99Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  89OriginAl reseArcHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AHMT .S5795 0Determinants of utilization of a no-cost HiV   transition clinic: a cross-sectional study   of young adults living with HiV/AiDs Agnes n yabigambo1,2,* Joshua Kanaabi Muliira3,* lynn Atuyambe1,* Harriet M Babikako1,* Andrew Kambugu2,* christopher ndoleriire4,* 1school of Public Health, 2infectious  Diseases institute, college of Health  sciences, Makerere University,   Kampala, Uganda; 3college of nursing,   sultan Qaboos University, Al Khod,   Muscat, Oman; 4Department of enT,   college of Health sciences, Makerere  University, Kampala, Uganda *These authors contributed equally to  this work correspondence: Agnes nyabigambo   school of Public Health, college of   Health sciences, Makerere University,   PO Box 7072, Kampala, Uganda   T el +256 774 135496   Fax +256 312 307291   email agagnesgn95@gmail.co mAbstract:  There is minimal research that has been conducted among young adults to understand  the determinants of the utilization of human immunodeficiency virus (HIV) health services in this  population.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Available  from: http://www.who.int/hiv/pub/ towards_universal_access_report_2008 .,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Available from: http://www.unaids.org/en/media/unaids/contentassets/docu - ments/unaidspublication/2011/ jc2216_worldaidsday_report_2011_en .pdf.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Available from: http://acetuganda.wordpress.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
"Available  from: http://health.vic.gov.au/subacute/literature-review.pd f. Accessed  January 7, 2011.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Available from: http://www.idi-makerere.com/index.php?option =  com_docman&task =doc_view&gid =11&tmpl =component&   format =raw&Itemid =58.,OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
Available from: http://www.who.int/gender/hiv_aids/en /.,Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
"Kampala: Uganda Ministry  of Health; 2011. http://www.k4health.org/toolkits/uganda-positiveliving - communication/integrated-national-guid e. Accessed on April 9, 2012.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/ahmt-5-089.PMC4043429.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/26/copd-9-543.PMC4043430.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 543–549International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  543OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/COPD.S6270 0Increased serum levels of lipocalin-1 and -2  in patients with s table chronic obstructive  pulmonary disease Xiao-ru Wang1,* Y ong-pu li2,* shui gao2 Wei Xia2 Kun gao1 Qing-hua Kong1 hui Qi1 ling Wu1 Jing Zhang3 Jie-ming Qu4 Chun-xue Bai3 1Department of Pulmonary Medicine,   Dahua hospital, Xuhui District,   shanghai,  2Department of Pulmonary  Medicine, People’s hospital of  Changshou, Chongqing,  3Department  of Pulmonary Medicine, Zhongshan  hospital,  4Department of Pulmonary  Medicine, huadong hospital, Fudan  University, shanghai, People’s republic  of China *These two authors contributed  to this paper equally Correspondence: Jing Zhang   Department of Pulmonary Medicine,  Zhongshan hospital, Fudan University,   180 Feng lin road, shanghai  200032,  People’s republic of China   email zhang.jing@zs-hospital.sh.c n    Jie-ming Qu   Department of Pulmonary Medicine,  huadong hospital, Fudan University,   221 Yananxi road, shanghai  200040,  People’s republic of China   email jmqu0906@163.co mAbstract:  Despite a number of studies on biomarkers in chronic obstructive pulmonary  disease (COPD), only a few disease-related markers have been identified, yet we still have  no satisfactory markers specific to innate immune system and neutrophil activation, which is  essential in airway inflammation in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/26/copd-9-543.PMC4043430.pdf
"Available from: http://www.goldcopd.org/Guidelines/   guidelines-global-strategy-for-diagnosis-management-2003-3.htm l.  Accessed April  1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/71/26/copd-9-543.PMC4043430.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/71/26/copd-9-543.PMC4043430.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/26/copd-9-543.PMC4043430.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/4e/copd-9-533.PMC4043431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2014:9 533–542International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  533OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6391 1a randomized controlled trial of inhaled  corticosteroids (ICs) on markers of epithelial– mesenchymal transition (eMT) in large airway  samples in COPD: an exploratory proof of  concept study sukhwinder singh sohal1,* amir soltani1,* David reid1,2 Chris Ward1,3 Karen e Wills1,4 h Konrad Muller1 eugene haydn Walters1 1national health and Medical  research Council Centre of research  excellence for Chronic respiratory  Disease, school of Medicine,   University of Tasmania, hobart,   Tasmania, australia;  2Iron Metabolism  laboratory, Queensland Institute  of Medical research, Brisbane,   Queensland, australia;  3Institute  of Cellular Medicine, newcastle  University, newcastle upon Tyne,   Tyne and Wear, UK;  4Department  of Biostatistics, Menzies research  Institute Tasmania, University of  Tasmania, hobart, Tasmania, australia *These authors contributed equally to  this work Correspondence: eugene haydn Walters   national health and Medical research  Council Centre for research excellence  in Chronic respiratory Disease and  school of Medicine, Ms1,  17 liverpool  street, Private Bag  23, hobart, Tasmania,  australia   Tel +61 3 6226 4805  Fax +61 3 6226 7704  email haydn.walters@utas.edu.a uBackground:  We recently reported that epithelial–mesenchymal transition (EMT) is active  in the airways in chronic obstructive pulmonary disease (COPD), suggesting presence of  an active profibrotic and promalignant stroma.",Non-OADS,/arxiv_data1/oa_pdf/f9/4e/copd-9-533.PMC4043431.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f9/4e/copd-9-533.PMC4043431.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/4e/copd-9-533.PMC4043431.pdf
2010 Aug 1; Available at:  http://www.voco.com/asia/products/_products/ Remin_Pro/GI_Remin_Pro_16 spr_0210.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c2/04/jod-11-131.PMC4043543.pdf
"Available at: http://www.cdc.gov/brfss/technical_ infodata/surveydata/2009.htm Accessed December 24, 2010.",OADS,/arxiv_data1/oa_pdf/2e/7e/wjem-15-251.PMC4043558.pdf
"Until now, mutations in 204 genes were found to be involved Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> Received 3 December 2013 | Accepted 30 May 2014 | Published 2 June 2014© 2014 Molecular Vision 753Novel compound heterozygous NMNAT1  variants associated with  Leber congenital amaurosis Anna M. Siemiatkowska,1 L. Ingeborgh van den Born,2 Maria M. van Genderen,3 Mette Bertelsen,4,5,6 Ditta  Zobor,7 Klaus Rohrschneider,8 Ramon A.C. van Huet,9 Siska Nurohmah,1,10 B. Jeroen Klevering,9 Susanne  Kohl,7 Sultana M.H.",Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  754in the pathogenesis of IRDs ( RetNet ).,Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
"Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  755both mutations were cloned in the TOPO vector containing  an ampicillin resistance cassette using the TOPO TA cloning  kit according to the manufacturer’s instructions (Invitrogen,  Breda, The Netherlands).",Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  756peripheral fundus pigmentation was visible in six patients.,Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  757Table  3. c linical  charac Teris Tics of paTienTs wiTh Two NMNAT1  varian Ts.,Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  758of these alterations on the protein.,Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
"Molecular Vision  2014; 20:753-759 <http://www.molvis.org/molvis/v 20/753> © 2014 Molecular Vision  759Mohand-Said S, Waseem NH, Jalali S, Perin JC, Place E,  Ostrovsky J, Xiao R, Bhattacharya SS, Consugar M, Webster  AR, Sahel JA, Moore AT, Berson EL, Liu Q, Gai X, Pierce  EA.",Non-OADS,/arxiv_data1/oa_pdf/2f/43/mv-v20-753.PMC4043607.pdf
"The mechanism underlying excess vascular permeability in Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> Received 19 September 2013 | Accepted 30 May 2014 | Published 2 June 2014© 2014 Molecular Vision 732Downregulation of Connexin 43 promotes vascular cell loss and  excess permeability associated with the development of vascular  lesions in the diabetic retina Thomas Tien, Tetsuya Muto, Kevin Barrette, Lucky Challyandra, Sayon Roy Departments of Medicine and Ophthalmology, Boston University School of Medicine, Boston, MA Purpose:  To determine whether downregulation of Connexin 43 (Cx43) expression promotes development of acellular  capillaries (ACs), pericyte loss (PL), excess permeability, and retinal thickening in rat retinas.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  733diabetic retinopathy is not well understood.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  734the secondary antibody as described for Cx43 antibody detec - tion.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
"Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  735ImmunoResearch, West Grove, PA).",Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  736was observed under a fluorescence microscope.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
"Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  737distance from the optic nerve head using a standard OCT  scanner software that included Line, Cross-line, and E-MM5  measurements.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  738injected retinas.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
"Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  739Downregulation of Cx43 promotes excess permeability  and retinal thickening:  To determine the effect of Cx43  downregulation on retinal vascular permeability, extravasa - tion of FITC-dextran was assessed in the retinal capillaries  following FITC-dextran injection.",Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  740calcium repletion.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
Molecular Vision  2014; 20:732-741 <http://www.molvis.org/molvis/v 20/732> © 2014 Molecular Vision  741Microvascular Endothelial Cells.,Non-OADS,/arxiv_data1/oa_pdf/15/d8/mv-v20-732.PMC4043608.pdf
"All seven identified adRP- causing splicing genes encode either important components  or regulators of U4/U6-U5 tri-snRNP complex, which is Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> Received 25 January 2014 | Accepted 30 May 2014 | Published 2 June 2014© 2014 Molecular Vision 770Mutation analysis of pre-mRNA splicing genes in Chinese families  with retinitis pigmentosa Xinyuan Pan,1 Xue Chen,1 Xiaoxing Liu,1 Xiang Gao,2 Xiaoli Kang,3 Qihua Xu,1 Xuejuan Chen,1 Kanxing  Zhao,4 Xiumei Zhang,2 Qiaomei Chu,5 Xiuying Wang,1 Chen Zhao1 (The first three authors contributed equally to this article) 1Department of Ophthalmology of the First Affiliated Hospital and State Key Laboratory of Reproductive Medicine, Nanjing  Medical University, Nanjing, China; 2Department of Ophthalmology, Jiaozuo Health College, Henan, China; 3Department  of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4Tianjin Medical  University, Tianjin Eye Hospital, Tianjin Key Laboratory of Ophthalmology and Visual Science, Tianjin, China; 5Department of  Ophthalmology, Liqun Hospital, Shanghai, China Purpose:  Seven genes involved in precursor mRNA (pre-mRNA) splicing have been implicated in autosomal dominant  retinitis pigmentosa (adRP).",Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  771required for proper splicing of pre-mRNA in nearly all types  of cells.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
"Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  772mouse ( Mus musculus ), zebrafish ( Danio rerio ), and fruit fly  (Drosophila melanogaster ).",Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
"Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  773Another recurrent mutation, SNRNP200  p.Ser1087Leu, was  identified in all patients studied in Family 03.",Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  774Table  2. c linical  Manifes TaTions of PaTienTs wiTh iden Tified  MuTaTions.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
"Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  775DISCUSSION To date, seven pre-mRNA splicing genes, including PRPF3 ,  PRPF6 , PRPF8 , PRPF31 , RP9, SNRNP200 , and PRPF4 , have  been identified as adRP-causing genes.",Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  776 Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  777particular attention has been paid to sample selection and  the approaches used.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  778mutations in the seven genes in patients with RP other than  adRP is needed.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
Molecular Vision  2014; 20:770-779 <http://www.molvis.org/molvis/v 20/770> © 2014 Molecular Vision  779and server for predicting damaging missense mutations.,Non-OADS,/arxiv_data1/oa_pdf/00/3c/mv-v20-770.PMC4043610.pdf
"Recently, researchers demonstrated [ 7] that a  resveratrol-based diet could significantly ameliorate disorders Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> Received 23 November 2013 | Accepted 30 May 2014 | Published 2 June 2014© 2014 Molecular Vision 760Pinosylvin-mediated protection against oxidative stress in human  retinal pigment epithelial cells Ali Koskela,1,2 Mika Reinisalo,1,2 Juha M. T. Hyttinen,2 Kai Kaarniranta,2,3 Reijo O. Karjalainen1 1Department of Biology, University of Eastern Finland, Kuopio, Finland; 2Department of Ophthalmology, Institute of Clinical  Medicine, University of Eastern Finland, Kuopio, Finland; 3Department of Ophthalmology, University Hospital Kuopio, Kuopio,  Finland Purpose:  In this work, we investigated the ability of pinosylvin (PS), 3,5-dihydroxy- trans -stilbene, to modulate oxidative  stress in human RPE cells.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  761related to cerebral ischemia and reperfusion; resveratrol treat - ment upregulated protein and mRNA expression of Nrf2 and  HO-1.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
"Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  762METHODS Cell culture:  The human retinal pigment epithelial (ARPE-19)  cell line obtained from American Type Culture Collection  (ATCC, Manassas, VA) was used in the study (passages  5–15).",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
"Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  763RESULTS Toxicity and protective effects of pinosylvin on oxidative  stress:  To determine the protective role of PS against oxida - tive stress, human retinal ARPE-19 cells were preincubated  in PS before oxidative stress was induced using HQ.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  764gene HO-1  were studied in conferring protection against  oxidative stress with qRT-PCR and cell viability test (Figure  6 and Figure 7).,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  765DISCUSSION Our data demonstrated that PS can protect RPE cells (ARPE- 19) from oxidative stress–induced cell death.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  766activated to compensate for increased protein damage.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
"Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  767been shown [ 15] to be a Nrf2 target, and Nrf2 can induce  the accumulation of p62.",Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  768APPENDIX 1.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
Molecular Vision  2014; 20:760-769 <http://www.molvis.org/molvis/v 20/760> © 2014 Molecular Vision  76918.,Non-OADS,/arxiv_data1/oa_pdf/b4/b3/mv-v20-760.PMC4043611.pdf
"Localization of circadian oscillators was also addressed more  recently by in vitro bioluminescence studies with transgenic  animals carrying a luciferase  reporter under the control of  Period  gene promoters, but these studies mainly concentrated  on expression profiles of one clock gene [ 17,26].Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> Received 30 December 2013 | Accepted 30 May 2014 | Published 2 June 2014© 2014 Molecular Vision 742Rat retina shows robust circadian expression of clock and clock  output genes in explant culture Daniella C. Buonfiglio,2 André Malan,1 Cristina Sandu,1 Catherine Jaeger,1 José Cipolla-Neto,2 David Hicks,1  Marie-Paule Felder-Schmittbuhl1 1Département Neurobiologie des Rythmes, Institut des Neurosciences Cellulaires et Intégratives, CNRS, Université de Strasbourg,  France; 2Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP ,  Brazil Purpose:  Circadian rhythms are central to vision and retinal physiology.",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  743Explanted tissues are well adapted to the investigation  of mechanisms generating autonomous biological rhythms  because they exclude other time-giving inputs, for instance,  from the central clock.",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  744thermal cycler conditions were as follows: 10 min at 95 °C,  and then 40 cycles of 15 s at 95 °C and 1 min at 60 °C.",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  745RQx = E-(Ctx - CtT28) where E = efficiency calculated with  the group of samples regarding the TaqMan set, CtT28 =  mean Ct value for the three samples at T28 (= calibrator),  Ctx = the Ct value for sample x.",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  746days of culture showed a cyclic profile (Figure 2) confirmed  with cosinor analysis , which consists in fitting a 24 h-period  sinusoid [ 29] (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  747 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  748studies led to the conclusion that most clock genes are  expressed in this tissue in mammals, without reaching any  consensus concerning cellular localization and description  of the retinal clockwork pathways [ 14,18-20,26,32,33].",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  749be in antiphase with that of Bmal1  [2,35].",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
"Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  750might be specifically and transiently induced by the process  of preparing explants, even if these clock genes do not show  cyclic activity in the retina in vivo, in constant conditions  [19].",Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  751study.,Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
Molecular Vision  2014; 20:742-752 <http://www.molvis.org/molvis/v 20/742> © 2014 Molecular Vision  75218.,Non-OADS,/arxiv_data1/oa_pdf/46/98/mv-v20-742.PMC4043612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0d/52/ijn-9-2627.PMC4043705.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2627–2634International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2627OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6231 5Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Fajardo-Ortiz et al Running head recto: Nanostructures: knowledge translation in cancer DOI: http://dx.doi.org/10.2147/IJN.S62315 David Fajardo-Ortiz1 luis Duran1 laura Moreno1 héctor Ochoa2  Víctor M castaño1,3,4 1Faculty of Medicine of the National  autonomous University of Mexico,   Mexico city, Mexico; 2el colegio  de la Frontera sur, san cristobal  de las casas, Mexico; 3Molecular  Material Department, applied Physics  and advanced T echnology center,   National autonomous University of  Mexico, Juriquilla, Mexico; 4advanced  T echnology center, cIaTeQ,   Queretaro, Mexico correspondence: Víctor M castaño   centro de Física aplicada y T ecnología  avanzada, Universidad Nacional  autónoma de México, Boulevard Juriquilla  3001, Juriquilla, Queretaro 76230, México T el +1 442 211 2657 Fax +1 442 192 6129 email meneses@unam.m xliposomes versus metallic nanostructures:  differences in the process of knowledge  translation in cancer Abstract:  This research maps the knowledge translation process for two different types of  nanotechnologies applied to cancer: liposomes and metallic nanostructures (MNs).",Non-OADS,/arxiv_data1/oa_pdf/0d/52/ijn-9-2627.PMC4043705.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/0d/52/ijn-9-2627.PMC4043705.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2634Fajardo-Ortiz et al  15.,Non-OADS,/arxiv_data1/oa_pdf/0d/52/ijn-9-2627.PMC4043705.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/67/ijn-9-2655.PMC4043706.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2655–2664International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2655OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5889 8Preparation and evaluation of tilmicosin-loaded  hydrogenated castor oil nanoparticle suspensions  of different particle sizes Xiaojin chen Ting Wang Mengmeng lu luyan Zhu Yan Wang WenZhong Zhou Department of Preventitive Veterinary  Medicine, college of Veterinary  Medicine, china agricultural  University, Beijing, People’s republic  of china correspondence: WenZhong Zhou   Department of Preventive Veterinary  Medicine, college of Veterinary   Medicine, china agricultural University,    2 Yuanmingyuan road West,   Beijing  100193, People’s republic   of china   Tel +86 106 273 4702  Fax +86 106 273 4840  email zhouwz@cau.edu.c nAbstract:  Three tilmicosin-loaded hydrogenated castor oil nanoparticle (TMS-HCO-NP)  suspensions of different particle sizes were prepared with different polyvinyl alcohol surfactant  concentrations using a hot homogenization and ultrasonic technique.",Non-OADS,/arxiv_data1/oa_pdf/77/67/ijn-9-2655.PMC4043706.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/77/67/ijn-9-2655.PMC4043706.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/67/ijn-9-2655.PMC4043706.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/2b/ijn-9-2439.PMC4043707.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2439–2458International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2439OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5848 7Interaction of gelatin with polyenes modulates   antifungal activity and biocompatibility   of electrospun fiber mats rajamani  lakshminarayanan1,2 radhakrishnan sridhar3,4 Xian Jun loh5 Muruganantham  Nandhakumar1 Veluchamy amutha  Barathi1,6 Madhaiyan Kalaipriya3,4 Jia lin Kwan1 shou Ping liu1,2 roger Wilmer Beuerman1,2 seeram ramakrishna3,4,7 1singapore eye research Institute,   2signature research Program in  Neuroscience and Behavioral  Disorders, Duke-NUs graduate  Medical school,  3Department of  Mechanical engineering, National  University of singapore,  4center for  Nanofibers and Nanotechnology,   National University of singapore,   5Institute of Materials research and  engineering, a*sTar (agency for  science, T echnology and research),   3 research link, singapore,   6Department of Ophthalmology, Y ong  loo lin school of Medicine, National  University of singapore,  7NUs  Nanoscience and Nanotechnology  Initiative, singapore correspondence: rajamani  lakshminarayanan   singapore eye research Institute,   11 Third hospital avenue,   singapore  168751   email lakshminarayanan.rajamani@seri.",Non-OADS,/arxiv_data1/oa_pdf/66/2b/ijn-9-2439.PMC4043707.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/66/2b/ijn-9-2439.PMC4043707.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/2b/ijn-9-2439.PMC4043707.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/b3/dmso-7-185.PMC4043708.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 185–194Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  185ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6261 0Regulation of dipeptidyl peptidase  4 production   in adipocytes by glucose Siddhartha Shankar Das Hiroto Hayashi Taiki Sato Ren Yamada Masahiro Hiratsuka Noriyasu Hirasawa Laboratory of Pharmacotherapy of  Life-Style Related Diseases, Graduate  School of Pharmaceutical Sciences,   T ohoku University, Sendai, Miyagi,   Japan Correspondence: Noriyasu Hirasawa   Laboratory of Pharmacotherapy of Life- Style Related Diseases, Graduate School  of Pharmaceutical Sciences, Tohoku  University,  6-3 Aoba Aramaki, Aoba-Ku,  Sendai, Miyagi, Japan  982-0841   Tel +81 22 795 5915  Fax +81 22 795 5504  Email hirasawa@m.tohoku.ac.j pObjective:  Type  1 and 2 diabetes are characterized by elevated blood glucose levels and  increased dipeptidyl peptidase  4 (DPP4) activity levels in the serum.",Non-OADS,/arxiv_data1/oa_pdf/16/b3/dmso-7-185.PMC4043708.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/16/b3/dmso-7-185.PMC4043708.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/b3/dmso-7-185.PMC4043708.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/e0/dddt-8-609.PMC4043709.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 609–619Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  609Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5662 5Quinoxaline-substituted chalcones as new  inhibitors of breast cancer resistance protein  ABCG2: polyspecificity at B-ring position evelyn Winter1,2,* gustavo Jabor gozzi1,3,* louise Domeneghini  chiaradia-Delatorre4 nathalia Daflon-Yunes1 raphael T erreux5 charlotte gauthier1 alessandra Mascarello4 Paulo césar leal4 silvia M cadena3 rosendo augusto Yunes4 ricardo José nunes4 Tania Beatriz creczynski- Pasa2 attilio Di Pietro1 1equipe labellisée ligue  2013,   Université lyon 1, institut de Biologie  et chimie des Protéines, lyon, France;   2Department of Pharmaceutical  sciences, Federal University of  santa catarina, Florianopolis, Brazil;   3Department of Biochemistry  and Molecular Biology, Federal  University of Paraná, curitiba,   Brazil;  4Department of chemistry,   Federal University of santa catarina,   Florianopolis, Brazil;  5Bioinformatique  structures et interactions, Université  lyon  1, institut de Biologie et chimie  des Protéines, lyon, France *These authors contributed equally to  this work correspondence: attilio Di Pietro   equipe labellisée ligue  2013, BMssi UMr   5086 cnrs/Université lyon  1, institut   de Biologie et chimie des Protéines,   7 Passage du Vercors,  69367   lyon cedex  07, France   Tel +33 4 7272 2629  Fax +33 4 7272 2629  email a.dipietro@ibcp.f rAbstract:  A series of chalcones substituted by a quinoxaline unit at the B-ring were synthesized  and tested as inhibitors of breast cancer resistance protein-mediated mitoxantrone efflux.",Non-OADS,/arxiv_data1/oa_pdf/8d/e0/dddt-8-609.PMC4043709.pdf
Available  from: http://www.who.int/gho/ncd/mortality_morbidity/cancer/en/index.,Non-OADS,/arxiv_data1/oa_pdf/8d/e0/dddt-8-609.PMC4043709.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8d/e0/dddt-8-609.PMC4043709.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/e0/dddt-8-609.PMC4043709.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/59/ijn-9-2581.PMC4043710.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2581–2595International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2581OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6347 2Matthieu F Dumont1 sridevi Yadavilli2 raymond W sze1,4 Javad Nazarian2,3 rohan Fernandes1,4,5 1sheikh Zayed Institute for Pediatric  surgical Innovation, 2center for  genetic Medicine research, children’s  National Medical center, Washington,   Dc, Usa; 3Department of Integrative  systems Biology, 4Department of  radiology, 5Department of Pediatrics,   george Washington University,   Washington, D c, Usa  correspondence: rohan Fernandes   sheikh Zayed Institute for Pediatric  surgical Innovation, children’s National  Medical center, 111 Michigan ave NW,  Washington, Dc 20010, Usa   T el +1 202 476 5290   email rFernand@childensnational.or gManganese-containing Prussian blue nanoparticles  for imaging of pediatric brain tumors Abstract:  Pediatric brain tumors (PBTs) are a leading cause of death in children.",Non-OADS,/arxiv_data1/oa_pdf/22/59/ijn-9-2581.PMC4043710.pdf
"In this paper, we describe a manganese-containing Prussian blue Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Dumont et al Running head recto: Prussian blue nanoparticles for imaging pediatric brain tumors DOI: http://dx.doi.org/10.2147/IJN.S63472",Non-OADS,/arxiv_data1/oa_pdf/22/59/ijn-9-2581.PMC4043710.pdf
"Dove pres sInternational Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/22/59/ijn-9-2581.PMC4043710.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2595Prussian blue nanoparticles for imaging pediatric brain tumors 1.0 K 00 200200 400400 600600 800800 1.0 K1.0 K 00 200200 400400 600600 800800 1.0 K1.0 K 00 200200 400400 600600 800800 1.0 KB 1.0 K 00 200200 400400 600600 800800 1.0 K1.0 K 00 200200 400400 600600 800800 1.0 KC Figure S7 Flow cytometric analysis of nanoparticle specificity for BSG D10 cells.,Non-OADS,/arxiv_data1/oa_pdf/22/59/ijn-9-2581.PMC4043710.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/e1/jaa-7-085.PMC4043711.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2014:7 85–94Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  85Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S4724 3elimination diets in the management   of eosinophilic esophagitis Joshua B wechsler Sally Schwartz Katie Amsden Amir F Kagalwalla Department of Pediatrics, Division  of Gastroenterology, Hepatology  and Nutrition, Ann & Robert H. Lurie  Children’s Hospital of Chicago, iL,   USA Correspondence: Amir F Kagalwalla   Department of Pediatrics, Division  of Gastroenterology, Hepatology and  Nutrition, Ann & Robert H. Lurie  Children’s Hospital of Chicago, 225 e.  Chicago Ave, Chicago, iL 60611, USA   T el +1 312 227 4200   Fax +1 312 227 9645   email akagalwalla@luriechildrens.or gAbstract:  Eosinophilic esophagitis, an increasingly recognized chronic inflammatory disorder  isolated to the esophagus, is triggered by an abnormal allergic response to dietary antigens.",Non-OADS,/arxiv_data1/oa_pdf/76/e1/jaa-7-085.PMC4043711.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/76/e1/jaa-7-085.PMC4043711.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/e1/jaa-7-085.PMC4043711.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2635–2653International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2635OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5983 4Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Salunke et al Running head recto: P. zeylanica -mediated synthesis of NPs and antibiofilm activity DOI: http://dx.doi.org/10.2147/IJN.S59834 Rapid efficient synthesis and characterization  of silver, gold, and bimetallic nanoparticles from  the medicinal plant Plumbago zeylanica  and their  application in biofilm control Correspondence: Balu A Chopade Department of Microbiology, University  of Pune, Ganeshkhind, Pune-411007,  Maharashtra, India T el +91 20 2569 0643 Fax +91 20 2569 0087 email chopade@unipune.ac.i nGayatri R Salunke1 Sougata Ghosh1 RJ Santosh Kumar2 Samiksha Khade1 Priya Vashisth3 Trupti Kale4 Snehal Chopade5 Vikas Pruthi3 Gopal Kundu4 Jayesh R Bellare6 Balu A Chopade1,5 1Institute of Bioinformatics   and Biotechnology, University   of Pune, 2National Chemical  Laboratory, Pune, 3Department   of Biotechnology, Indian Institute  of T echnology, Roorkee, 4National  centre for cell science, Pune  University Complex, 5Department  of Microbiology, University of Pune,   Pune, 6Department of Chemical  engineering, Indian Institute   of T echnology Bombay, Powai,    Mumbai, IndiaBackground:  Nanoparticles (NPs) have gained significance in medical fields due to their high  surface-area-to-volume ratio.",Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
Available from: http://www.cytodiagnostics.com.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
Available from: http://grants.nih.gov/grants/guide/rfa-files/ RFA-DE-98-006.html.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2653P.,Non-OADS,/arxiv_data1/oa_pdf/df/7b/ijn-9-2635.PMC4043712.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/87/ijn-9-2699.PMC4043713.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2699–2712International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2699OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6196 4Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Khandaker et al Running head recto: Effect of additive particles on PMMA cement DOI: http://dx.doi.org/10.2147/IJN.S61964 effect of additive particles on mechanical, thermal,  and cell functioning properties of poly(methyl  methacrylate) cement Morshed Khandaker1 Melville B Vaughan2 Tracy l Morris3 Jeremiah J White1 Zhaotong Meng1 1Department of engineering and  Physics, 2Department of Biology,   3Department of Mathematics and  statistics, University of central  Oklahoma, edmond, OK, Usa correspondence: Morshed Khandaker   Department of engineering and Physics,  University of central Oklahoma,  100 N University Drive, edmond,   OK 73034, Usa   T el +1 405 974 5935   Fax +1 405 974 3812   email mkhandaker@uco.eduAbstract:  The most common bone cement material used clinically today for orthopedic surgery is  poly(methyl methacrylate) (PMMA).",Non-OADS,/arxiv_data1/oa_pdf/e3/87/ijn-9-2699.PMC4043713.pdf
Available  from: http://www.andersonclinic.com/specialties/total-hip-replacement- arlington-alexandria-virginia.php.,Non-OADS,/arxiv_data1/oa_pdf/e3/87/ijn-9-2699.PMC4043713.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/87/ijn-9-2699.PMC4043713.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 2712Khandaker et al  4.,Non-OADS,/arxiv_data1/oa_pdf/e3/87/ijn-9-2699.PMC4043713.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/60/ijn-9-2607.PMC4043714.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2607–2617International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2607OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5985 9In situ precipitation: a novel approach for  preparation of iron-oxide magnetoliposomes shudong Xia1  Peng li1 Qiang chen1  Malik armah2  Xiaoying Ying3  Jian Wu4 Jiangtao lai5 1Yiwu affiliated hospital, college  of Medicine,  2college of Medicine,   3college of Pharmacy,  4college of  Nanotechnology,  5First affiliated  hospital, college of Medicine,   Zhejiang University, hangzhou,   People’s republic of china correspondence: Jiangtao lai   Department of cardiology, The First  Affiliated Hospital, College of Medicine,  Zhejiang University, hangzhou, People’s  republic of china   Tel +86 139 8989 7610  Fax +86 571 8723 6707  email shystone@126.co mBackground:  Conventional methods of preparing magnetoliposomes are complicated and  inefficient.",Non-OADS,/arxiv_data1/oa_pdf/90/60/ijn-9-2607.PMC4043714.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/90/60/ijn-9-2607.PMC4043714.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/60/ijn-9-2607.PMC4043714.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/06/ijn-9-2665.PMC4043715.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2665–2675International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2665OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5904 0Mesoporous magnesium silicate-incorporated  poly(ε-caprolactone)-poly(ethylene glycol)-   poly(ε-caprolactone) bioactive composite   beneficial to osteoblast behaviors Yunfei Niu1,* Wei Dong1,* han guo2 Yuhu Deng3 lieping guo1 Xiaofei an1 Dawei he1 Jie Wei3 Ming li1 1Department of Orthopedic surgery,   changhai hospital, second Military  Medical University, shanghai,   People’s republic of china;  2shanghai  synchrotron radiation Facility,   shanghai Institute of applied Physics,   chinese academy of sciences,   shanghai, People’s republic of  china;  3Key laboratory for Ultrafine  Materials of Ministry of education,   east china University of science  and Technology, shanghai, People’s  republic of china *These authors contributed equally   to this work correspondence: Dawei he; Ming li   Department of Orthopedic surgery,  changhai hospital, second Military  Medical University, 168 changhai road,  shanghai  200433, People’s republic  of china   Tel +86 21 8187 3400  Fax +86 21 8187 3398  email dyt901208@qq.co m;  niuy1111@163.co m Abstract:  Mesoporous magnesium silicate (m-MS) and poly( ε-caprolactone)-poly(ethylene  glycol)-poly( ε-caprolactone) (PCL-PEG-PCL) composite (m-MPC) was synthesized by solvent  casting method.",Non-OADS,/arxiv_data1/oa_pdf/9d/06/ijn-9-2665.PMC4043715.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9d/06/ijn-9-2665.PMC4043715.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/06/ijn-9-2665.PMC4043715.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/0e/dddt-8-583.PMC4043716.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 583–600Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  583Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6028 3cytoprotective effect of selective   small-molecule caspase inhibitors against   staurosporine-induced apoptosis Jianghong Wu Yuren Wang shuguang liang haiching Ma reaction Biology corp, Malvern,    Pa, Usa correspondence: haiching Ma   reaction Biology corp,  1 great Valley   Parkway, suite  2, Malvern, P a 19355, Usa   Tel +1 610 722 0247  Fax +1 610 722 0246  email haiching.ma@reactionbiology.co mAbstract:  Caspases are currently known as the central executioners of the apoptotic pathways.",Non-OADS,/arxiv_data1/oa_pdf/8c/0e/dddt-8-583.PMC4043716.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/8c/0e/dddt-8-583.PMC4043716.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/0e/dddt-8-583.PMC4043716.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 159–168Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  159Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6232 0Holistic approach to prevention and management   of type  2 diabetes mellitus in a family setting Sandra N Ofori Chioma N Unachukwu Department of internal   Medicine, University of Port   Harcourt Teaching Hospital, Port   Harcourt, Rivers State, Nigeria Correspondence: SN Ofori   Department of internal Medicine,   University of Port Harcourt Teaching   Hospital, PMB 6173,   Choba,   Rivers State, Nigeria   Tel +234 809 659 8508  email sandytom77@yahoo.co mAbstract:  Diabetes mellitus (DM) is a chronic, progressive metabolic disorder with several  complications that affect virtually all the systems in the human body.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
Available from: http://databank.worldbank.org/data/views/ variableselection/selectvariables.aspx?source=world-development- indicators#s_ p. Accessed.,OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
"Available from: http://guidance.nice.org.uk/PH38  Accessed March  26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/fa/dmso-7-159.PMC4043717.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/5c/nss-6-065.PMC4043718.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 65–71Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  65OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S5372 1Obstructive sleep apnea and psychomotor  vigilance task performance Salma Batool-anwar1 Stefanos N Kales3,4 Sanjay r Patel1 Vasileia Varvarigou3 Pamela N DeY oung2 atul Malhotra2 1Department of Medicine, Sleep  Disorders Program, Brigham and  Women’s hospital , Boston, M a, USa;   2Pulmonary critical care Division,   University of california San Diego,   la Jolla, ca, USa; 3Department of  environmental and Occupational  Medicine and epidemiology, harvard  School of Public health, Boston,   4Department of Occupational  Medicine, The cambridge health  alliance, cambridge, M a, USa correspondence: Salma Batool-anwar   Department of Medicine, Sleep Disorders  Program, Brigham and Women’s  hospital, 221 longwood avenue,   Boston, Ma Bli 02115, USa  Tel +1 617 732 5033   Fax +1 617 732 7337   email sbatool@bics.bwh.harvard.ed uBackground:  Obstructive sleep apnea (OSA) is a highly prevalent disorder with considerable  morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/a4/5c/nss-6-065.PMC4043718.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/a4/5c/nss-6-065.PMC4043718.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/5c/nss-6-065.PMC4043718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 537–545International Journal of Women’s Health Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
"Or use: http://dvpr.es/1gVI9k fDove press submit your manuscript | www.dovepress.co m Dove press  537RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4089 4Clinical epidemiology of epithelial ovarian   cancer in the UK Konstantinos Doufekas Adeola Olaitan Department of Gynaecological  Oncology, University College   London Hospitals, London, UK Correspondence: Adeola Olaitan   Department of Gynaecological Oncology,  University College London Hospitals,   2nd Floor east, 250 euston Road,  London, UK, NW1 2PB   Tel +44 203 447 8636   Fax +44 3447 9883   email adeola.olaitan@uclh.nhs.u kAbstract:  Epithelial ovarian cancer is the fifth commonest cancer among women and the leading  cause of gynecological cancer death in the UK.",Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.rcog.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.ncin.org.uk/ cancer_type_and_topic_specific_work/cancer_type_specific_work/ gynaecological_cancer/gynaecological_cancer_hub/resources/ ovarian_cancer .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
"Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/file/213823/dh_117794.pd f.  Accessed January 10, 2014.",OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.nhs.uk/NHSEngland/ thenhs/about/Pages/overview.aspx .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://webarchive.nationalarchives.gov.uk/+/www.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.ncin.org.uk/cancer_type_and_topic_  specific_work/multidisciplinary_teams/mdt_development .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.ukacr.org /.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.nice.org.uk/nicemedia/ live/13464/54266/54266.pdf .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available  from: http://www.cancerresearchuk.org/cancer-help/type/ovarian-cancer/ about/ovarian-cancer-risks-and-causes .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.cancerre - searchuk.org/cancer-info/cancerstats/types/ovary/riskfactors /.,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.dailymail.co.uk/ health/article-2051374/Average-age-women-having-baby-climbs-29- start-family-later.html .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available  from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/ ovary/incidence/uk-ovarian-cancer-incidence-statistics .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
Available from: http://www.cancerresearchuk.org/about-us/cancer- news/press-release/differences-in-treatment-for-advanced-ovarian- cancer-could-explain-why-uk-survival-lags-behind-other .,Non-OADS,/arxiv_data1/oa_pdf/9c/f9/ijwh-6-537.PMC4043719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/27/ijn-9-2677.PMC4043720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2677–2687International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2677OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6194 0Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Herrán et al Running head recto: VEGF and GDNF nanospheres in a model of Parkinson’s disease DOI: http://dx.doi.org/10.2147/IJN.S61940 Abstract : Current research efforts are focused on the application of growth factors, such  as glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor  (VEGF), as neuroregenerative approaches that will prevent the neurodegenerative process in  Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/73/27/ijn-9-2677.PMC4043720.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/73/27/ijn-9-2677.PMC4043720.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2687VegF and gDNF nanospheres in a model of Parkinson’s disease  16.,Non-OADS,/arxiv_data1/oa_pdf/73/27/ijn-9-2677.PMC4043720.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/e5/ijn-9-2689.PMC4043721.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2689–2698International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2689OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6318 9Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Hunter et al Running head recto: Nanoparticles and calcification of vascular smooth muscle DOI: http://dx.doi.org/10.2147/IJN.S63189 calcifying nanoparticles promote mineralization   in vascular smooth muscle cells: implications   for atherosclerosis larry W hunter1 Jon e charlesworth2 sam Yu3,4 John c lieske5,6 Virginia M Miller1,7 1Department of surgery, 2Department  of Biochemistry and Molecular  Biology, Mayo clinic, rochester,   MN, Usa; 3lincoln University,   christchurch, New Zealand;    4Izon science ltd., christchurch,    New Zealand; 5Department   of Internal Medicine, Division   of Nephrology and hypertension;   6Department of laboratory   Medicine and Pathology;    7Department of Physiology   and Biomedical engineering, Mayo  clinic, rochester, MN, Usa correspondence: Virginia M Miller   Department of surgery, Mayo clinic,  200 First st sW, rochester,   MN 55905, Usa   T el +1 507 284 2290   Fax +1 507 266 2233   email miller.virginia@mayo.ed uBackground:  Nano-sized complexes of calcium phosphate mineral and proteins (calcifying  nanoparticles [CNPs]) serve as mineral chaperones.",Non-OADS,/arxiv_data1/oa_pdf/6a/e5/ijn-9-2689.PMC4043721.pdf
Available from: http://www.who.int/mediacentre/fact - sheets/fs310_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6a/e5/ijn-9-2689.PMC4043721.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6a/e5/ijn-9-2689.PMC4043721.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2698hunter et al 22.,Non-OADS,/arxiv_data1/oa_pdf/6a/e5/ijn-9-2689.PMC4043721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 169–183Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  169Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6143 8importance of cardiovascular disease risk  management in patients with type  2   diabetes mellitus Daniel Lorber Division of endocrinology, New York  Hospital Queens, Department of  Medicine, weill Medical College   of Cornell University, New Y ork,    NY, USA Correspondence: Daniel Lorber   Division of endocrinology, New York  Hospital Queens,  5945 161st Street,  Flushing, New York, NY  11365, USA   Tel +1 718 762 3111  Fax +1 718 353 6315  email lorberdan@aol.co mAbstract:  Type  2 diabetes mellitus (T2DM) is commonly accompanied by other cardiovascular  disease (CVD) risk factors, such as hypertension, obesity, and dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
Available from: http://www.fda.gov/  downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances /ucm071627.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
Available from: http://www.accessdata.fda.gov/   drugsatfda_docs/label/2010/022307s002lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/022433s008lbl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7a/f3/dmso-7-169.PMC4043722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/3f/ijn-9-2619.PMC4043723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2619–2626International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2619OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6234 3Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Liu et al Running head recto: Amplified voltammetric detection of glycoproteins DOI: http://dx.doi.org/10.2147/IJN.S62343 Amplified voltammetric detection of glycoproteins  using 4-mercaptophenylboronic acid/biotin-modified  multifunctional gold nanoparticles as labels lin liu1,2 Yun Xing1 Hui Zhang1 ruili liu1 Huijing Liu1 Ning Xia1,2 1College of Chemistry and Chemical  Engineering, Anyang Normal  University, Anyang, Henan, People’s  Republic of China; 2College of  Chemistry and Chemical Engineering,   Central South University, Changsha,   Hunan, People’s Republic of China correspondence: lin liu   College of Chemistry and Chemical  Engineering, Anyang Normal University,  Anyang, Henan 455000,   People’s Republic of China   email  liulin@aynu.edu.c n Ning Xia   College of Chemistry and Chemical  Engineering, Anyang Normal University,  Anyang, Henan 455000,   People’s Republic of China   T el +86 372 290 0370   email xianing82414@csu.edu.c nAbstract:  Ultrasensitive detection of protein biomarkers is essential for early diagnosis and  therapy of many diseases.",Non-OADS,/arxiv_data1/oa_pdf/19/3f/ijn-9-2619.PMC4043723.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/19/3f/ijn-9-2619.PMC4043723.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 2626liu et al 35.,Non-OADS,/arxiv_data1/oa_pdf/19/3f/ijn-9-2619.PMC4043723.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/76/ijn-9-2597.PMC4043724.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2597–2606International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2597OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5965 4Enhanced antifungal efficacy of tebuconazole   using gated ph-driven mesoporous nanoparticles Núria Mas1–3 Irene galiana3 silvia hurtado† laura Mondragón1–3 andrea Bernardos1–3 Félix sancenón1–3 María D Marcos1–3 Pedro amorós4 Nuria Abril-Utrillas5 Ramón Martínez-Máñez1–3 José ramón Murguía1,3 1centro de reconocimiento Molecular  y Desarrollo T ecnológico (IDM),   Centro Mixto Universidad Politécnica  de Valencia, Universidad de Valencia,   Valencia, spain; 2Departamento de  Química, Universidad Politécnica  de Valencia, Valencia, spain; 3cIBer  de Bioingeniería, Biomateriales y  Nanomedicina, Madrid, spain; 4Institut  de Ciència del Materials (ICMUV),   Universitat de València, Valencia, Spain;   5Servicio Ginecología y Obstetricia,   hospital de la Plana, Vila-real, spain †Silvia Hurtado passed away in  September 2013  correspondence: José ramón Murguía   Centro de Reconocimiento Molecular y  Desarrollo Tecnológico (IDM), Centro  Mixto Universidad Politécnica de Valencia,  Universidad de Valencia, Camino de Vera s/n,  46022 Valencia, spain   Tel +34 96 387 9416   Fax +34 96 387 9349   email muribajo@ibmcp.upv.e s    Ramón Martínez-Máñez   Centro de Reconocimiento Molecular y  Desarrollo Tecnológico (IDM), Centro  Mixto Universidad Politécnica de Valencia,  Universidad de Valencia, Camino de Vera  s/n, 46022 Valencia, Spain   Tel +34 96 387 7343   Fax +34 96 387 9349   email rmaez@qim.up vAbstract:  pH-sensitive gated mesoporous silica nanoparticles have been synthesized.",Non-OADS,/arxiv_data1/oa_pdf/6b/76/ijn-9-2597.PMC4043724.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6b/76/ijn-9-2597.PMC4043724.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/76/ijn-9-2597.PMC4043724.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ott-7-815.PMC4043796.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 815–821OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  815Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6000 0Prevalence and relationship between major  depressive disorder and lung cancer:   a cross-sectional study Benchalak Maneeton1 narong Maneeton1 Jirayu reungyos1 suthi intaprasert1 samornsri leelarphat1 sumitra Thongprasert2 1Department of Psychiatry,   2Department of Medicine, Faculty  of Medicine, chiang Mai University,  chiang Mai, Thailand correspondence: narong Maneeton   Department of Psychiatry, Faculty   of Medicine, chiang Mai University,   amphur Muang, chiang Mai  50200,  Thailand   Tel +66 53 945 422  Fax +66 53 217 144  email narong.m@cmu.ac.t hObjective:  The aims of this study were to estimate the prevalence and examine the factors  associated with major depressive disorder (MDD) in lung cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ott-7-815.PMC4043796.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ott-7-815.PMC4043796.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/eb/ott-7-815.PMC4043796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/tcrm-10-373.PMC4043797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 373–380Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  373REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4566 7Evolving treatment approaches for the  management of metastatic castration-resistant  prostate cancer – role of radium-223 Deborah Mukherji1 Imane El Dika1 Sally T emraz1 Mohammed Haidar2 Ali Shamseddine1 1Department of Hematology/ Oncology,  2Department of Nuclear  Medicine, American University  of Beirut Medical Center, Beirut,   Lebanon Correspondence: Deborah Mukherji   Department of Hematology/Oncology,  American University of Beirut Medical  Center, PO Box:  11-0236, Riad El Solh,  Beirut  1107 202, Lebanon   Tel +961 135 0000  Email d m25@aub.edu.l bAbstract:  Radium-223 is a first-in-class alpha particle-emitting radiopharmaceutical approved for  the treatment of bone metastatic castration-resistant prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/tcrm-10-373.PMC4043797.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/27/5d/tcrm-10-373.PMC4043797.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/5d/tcrm-10-373.PMC4043797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/30/bc/ppa-8-763.PMC4043798.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 763–773Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  763Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S3033 9Patient adherence issues in the treatment   of hepatitis C Dominique Larrey1,2 Marie-Pierre Ripault1 Georges-Philippe Pageaux1 1Département d’Hépato- Gastroentérologie et Transplantation,   Hôpital Saint eloi, 2iRB-iNSeRM1040,   Montpellier, France Correspondence: Dominique Larrey   Département d’Hépato-   Gastroentérologie et Transplantation,   Hôpital Saint eloi, 80 rue Augustin Fliche,   34295 Montpellier Cedex 5, France   Tel +33 4 67 33 70 61   Fax +33 4 67 33 02 57   email dom-larrey@chu-montpellier.f rAbstract:  The current standard-of-care treatments for chronic hepatitis C, based on a bitherapy  that combines peginterferon alpha-2a or -2b and ribavirin for all genotypes, and on a triple therapy  with the addition of an antiprotease specifically for genotype 1, are associated with a limited  adherence that decreases their efficacy.",Non-OADS,/arxiv_data1/oa_pdf/30/bc/ppa-8-763.PMC4043798.pdf
"Available from: http://www.euro.who.int/__data/ assets/pdf_file/0009/145296/E93849.pd f. Accessed March 1, 2014.",OADS,/arxiv_data1/oa_pdf/30/bc/ppa-8-763.PMC4043798.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/30/bc/ppa-8-763.PMC4043798.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/bc/ppa-8-763.PMC4043798.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/e4/oajsm-5-137.PMC4043799.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Journal of Sports Medicine 2014:5 137–141Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  137OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S6365 6incidence of familial tendon dysfunction   in patients with full-thickness rotator cuff tears robert Z Tashjian erik g Saltzman erin K granger Man hung Department of Orthopedics,   University of Utah Orthopaedic  center, University of Utah School   of Medicine, Salt lake city, UT, USA correspondence: robert Z Tashjian   Department of Orthopedics, University   of Utah Orthopaedic center, University   of Utah School of Medicine, 590 Wakara   Way, Salt lake city, UT 84108, USA   Tel +1 801 587 5457   Fax +1 801 587 5411   email r obert.",Non-OADS,/arxiv_data1/oa_pdf/be/e4/oajsm-5-137.PMC4043799.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/be/e4/oajsm-5-137.PMC4043799.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e4/oajsm-5-137.PMC4043799.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/2b/opth-8-1039.PMC4043800.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1039–1045Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1039Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5903 6Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Badawi and Hegazy Running head recto: Y-split recession vs BMR for infantile esotropia DOI: http://dx.doi.org/10.2147/OPTH.S59036 Comparative study of Y -split recession versus  bilateral medial rectus recession for surgical  management of infantile esotropia nermeen Badawi Khaled hegazy Ophthalmology Department, Faculty  of Medicine, Menoufiya University,   shebin el-Kom, Menoufiya, egyptAim:  This prospective study compares the results of bilateral medial rectus recession versus  (vs) Y-split recession of medial recti techniques for surgical management of essential infantile  esotropia.",Non-OADS,/arxiv_data1/oa_pdf/ed/2b/opth-8-1039.PMC4043800.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ed/2b/opth-8-1039.PMC4043800.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1045Y -split recession vs BMr for infantile esotropia who have undergone Y-split recession have been reoperated  on a few months later.,Non-OADS,/arxiv_data1/oa_pdf/ed/2b/opth-8-1039.PMC4043800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/82/ccid-7-165.PMC4043801.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 165–170Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  165RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S3732 7Use of tazarotene foam for the treatment   of acne vulgaris Stamatis Gregoriou eleftheria Kritsotaki Alexandros Katoulis Dimitris Rigopoulos Second Department of Dermatology  and venereology, Attikon Hospital,   University of Athens Medical School,   Athens, Greece Correspondence: Dimitris Rigopoulos   Second Department of Dermatology   and venereology, Attikon Hospital,   University of Athens Medical School,   1 Rimini Street, Athens 12462, Greece   Tel +30 21 0583 2396   Fax +30 21 0583 2397   email stamgreg@yahoo.g rAbstract:  Acne vulgaris is a common inflammatory chronic disease of the pilosebaceous unit.",Non-OADS,/arxiv_data1/oa_pdf/ee/82/ccid-7-165.PMC4043801.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ee/82/ccid-7-165.PMC4043801.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/82/ccid-7-165.PMC4043801.pdf
A vailable from:  http://clinicaltrials.gov/ct2/show/results/NCT01017146?sect=Xf01 5.,Non-OADS,/arxiv_data1/oa_pdf/ee/82/ccid-7-165.PMC4043801.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/fd/opth-8-1031.PMC4043802.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1031–1038Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1031Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4629 8an observational study of bimatoprost 0.01%   in patients on prior intraocular pressure-lowering  therapy: the Canadian lumigan® rC early analysis  review (Clear) trial andrew C Crichton1 Donald r nixon2 susan simonyi3 Meetu Bhogal3 Christopher s sigouin4 Marino J Discepola5 Cindy M l hutnik6 Darryl C Baptiste3 David B Yan7 On behalf of the Clear   study group 1Division of Ophthalmology, University  of Calgary, Calgary, aB, Canada;  2Private practice, Barrie, On , Canada;  3Medical affairs, allergan inc., Markham,  On, Canada; 4Clin West research,  Burlington, On , Canada; 5Department  of Ophthalmology, Mcgill University,  Montreal, QC, Canada; 6Department of  Ophthalmology and Pathology, ivey eye  institute, london, On , Canada;  7Department of Ophthalmology,  University of T oronto, T oronto, On ,  Canada Correspondence: andrew Crichton   Division of Ophthalmology, Faculty of  Medicine, University of Calgary,   102-49 richard Way sW, Calgary,   aB T3e 7M8, Canada   Tel +1 403 245 3730   Fax +1 403 245 1058   email drcricht@telusplanet.ne tPurpose:  To evaluate the ocular hyperemia and intraocular pressure (IOP)-lowering efficacy of  bimatoprost 0.01% in subjects with elevated IOP due to primary open-angle glaucoma (POAG)  or ocular hypertension (OHT) in a real-world clinical setting.",Non-OADS,/arxiv_data1/oa_pdf/5f/fd/opth-8-1031.PMC4043802.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/fd/opth-8-1031.PMC4043802.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/fd/opth-8-1031.PMC4043802.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 775–788Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  775Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6124 8Journal name: Patient Preference and Adherence Journal Designation: Review Y ear: 2014 Volume: 8 Running head verso: Hall et al Running head recto: Dose-memory functions on adherence, confidence, and self-management DOI: http://dx.doi.org/10.2147/PPA.S61248 The effect of medical device dose-memory  functions on patients’ adherence to treatment,  confidence, and disease self-management Rebecca L Hall1 Thomas Willgoss1 Louise J Humphrey1 Jens Harald Kongsø2 1Adelphi values, Adelphi Mill,   Bollington, Cheshire, UK; 2Novo  Nordisk A/S, Novo Allé, Bagsværd,   Denmark Correspondence: Rebecca L Hall   Adelphi Values, Adelphi Mill, Bollington,  Cheshire, UK   T el +44 1625 576 815 Fax +44 1625 577 328   email rebecca.hall@adelphivalues.co mBackground:  Adherence to treatment is an important issue in chronic disease management  and an indicator of patients’ ability to self-manage their condition and treatment.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
Available from: http://www.who.int/chp/knowledge/ publications/adherence_report/en /.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
Available from: http://www.adultmeducation.com/downloads/ Adult_Meducation.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
"Available at: http://www.bcg.com/docu - ments/file14265.pd f. Accessed April 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focusing on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/ppa-8-775.PMC4043803.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/c6/ott-7-807.PMC4043804.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 807–813OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  807Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6270 7Preliminary analysis of the risk factors   for radiation pneumonitis in patients with non-   small-cell lung cancer treated with concurrent   erlotinib and thoracic radiotherapy hongqing Zhuang* hailing hou* Zhiyong Yuan Jun Wang Qingsong Pang lujun Zhao Ping Wang Department of radiotherapy,    Tianjin Medical University cancer   institute and hospital, national   clinical research center for cancer,    Tianjin Key laboratory of cancer   Prevention and Therapy, and Tianjin   lung cancer center, Tianjin,    People’s republic of china *These authors contributed equally   to this work correspondence: hongqing Zhuang;   Ping Wang   Department of radiotherapy,   Tianjin Medical University cancer   institute and hospital, Tianjin, 300060,   People’s republic of china   Tel +86 22 2334 1405  Fax +86 22 2334 1405  email hongqingzhuang@163.co m;   ping_wang999@163.co mPurpose:  The aim of this study was to investigate radiation pneumonitis and its associated  risk factors in patients with non-small-cell lung cancer treated with concurrent erlotinib and  thoracic radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/c7/c6/ott-7-807.PMC4043804.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c7/c6/ott-7-807.PMC4043804.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/c6/ott-7-807.PMC4043804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/1f/ott-7-799.PMC4043805.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 799–805OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  799Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6263 9Prior egFr tyrosine-kinase inhibitor therapy  did not influence the efficacy of subsequent  pemetrexed plus platinum in advanced  chemonaïve patients with egFr-mutant lung  adenocarcinoma Jeng-sen Tseng1,2 Tsung-Ying Yang2 Kun-chieh chen1,2 Kuo-hsuan hsu1,3 chong-Jen Yu4 Wei-Yu liao4 chi-ren Tsai5,6 Meen-hsin Tsai2,7 sung-liang Yu8–11 Kang-Yi su8,12 Jeremy JW chen1 hsuan-Yu chen7 gee-chen chang1,2,13–15 1Institute of Biomedical Sciences, National Chung- hsing University, 2Division of Chest Medicine,  Department of Internal Medicine, Taichung  Veterans general hospital, 3Division of Critical  Care and Respiratory Therapy, Department of  internal Medicine, Taichung Veterans general  hospital, Taichung, 4Department of Internal  Medicine, national Taiwan University hospital and  National Taiwan University College of Medicine,  Taipei, 5Department of Pediatrics, Taichung  Veterans general hospital, 6Institute of Molecular  Biology, National Chung-Hsing University,  Taichung, 7Institute of Statistical Science, Academia  sinica, 8Department of Clinical Laboratory  Sciences and Medical Biotechnology, College of  Medicine, n ational Taiwan University, 9Center for  Optoelectronic Biomedicine, College of Medicine,  national Taiwan University, 10Graduate Institute of  Pathology, College of Medicine, National Taiwan  University, 11Department of Laboratory Medicine,  national Taiwan University hospital, 12Center of  genomic Medicine, national Taiwan University,  Taipei, 13School of Medicine, China Medical  University, 14comprehensive cancer center,  Taichung Veterans general hospital, Taichung,  15Faculty of Medicine, School of Medicine, National  Yang-Ming University, Taipei, Taiwan correspondence: gee-chen chang   Faculty of Medicine, School of Medicine,   national Yang-Ming University,   155 section  2 linong street, Taipei  112, Taiwan   Tel +886 4 2359 2525 ext  3250  Fax +886 4 2355 2590  email august@vghtc.gov.t wBackground:  Tumor cells before and after epidermal growth-factor receptor (EGFR)  tyrosine-kinase inhibitor (TKI) therapy might display different characteristics.",Non-OADS,/arxiv_data1/oa_pdf/3e/1f/ott-7-799.PMC4043805.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/1f/ott-7-799.PMC4043805.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/1f/ott-7-799.PMC4043805.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/19/opth-8-1047.PMC4043806.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1047–1050Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1047Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S6209 6Journal name: Clinical Ophthalmology Journal Designation: Case report Y ear: 2014 Volume: 8 Running head verso: Jarade et al Running head recto: Bilateral malignant glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S62096 spontaneous simultaneous bilateral malignant  glaucoma of a patient with no antecedent   history of medical or surgical eye diseases elias F Jarade1,2 ali Dirani3 elyse Jabbour3 Joelle antoun3 Karim F tomey1 1Beirut eye specialist Hospital, Beirut,   Lebanon; 2Mediclinic Dubai Mall,   Dubai, United arab emirates; 3Hotel  Dieu de France Hospital, saint Joseph  University, Beirut, LebanonPurpose:  Malignant glaucoma, or aqueous misdirection syndrome, is a condition characterized  by sudden intraocular pressure (IOP) elevation, and it is usually unilateral and induced by ocular  surgical intervention or by medical therapy.",Non-OADS,/arxiv_data1/oa_pdf/67/19/opth-8-1047.PMC4043806.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/67/19/opth-8-1047.PMC4043806.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1050Jarade et al in any of the products mentioned.,Non-OADS,/arxiv_data1/oa_pdf/67/19/opth-8-1047.PMC4043806.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/39/ott-7-835.PMC4043807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 835–840OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  835Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6205 7Cerium oxide nanoparticles in cancer Ying Gao1 Kan Chen2,* Jin-lu Ma1,* Fei Gao3 1Department of Radiotherapy  Oncology, First Affiliated Hospital  of Medical College of Xi’an Jiaotong  University, Xi’an, People’s Republic  of China;  2School of Life Sciences,   Zhejiang Sci-T ech University,   Hangzhou, People’s Republic of China;   3Department of Neurology, First  Affiliated Hospital of Xi’an Medical  University, Xi’an, People’s Republic of  China *These authors contributed equally  to this work Correspondence: Ying Gao   Department of Radiotherapy Oncology,  First Affiliated Hospital of Medical  College of Xi’an Jiaotong University,   277 west Yanta Road, Xi’an , Shaanxi  710061,  People’s Republic of China   Tel +86 29 8532 4019  email togaoying@163.co mAbstract:  With the development of many nanomedicines designed for tumor therapy, the diverse  abilities of cerium oxide nanoparticles (CONPs) have encouraged researchers to pursue CONPs  as a therapeutic agent to treat cancer.",Non-OADS,/arxiv_data1/oa_pdf/f2/39/ott-7-835.PMC4043807.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/39/ott-7-835.PMC4043807.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/39/ott-7-835.PMC4043807.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/2f/ott-7-829.PMC4043808.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 829–834OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  829Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OTT .S6174 0serial changes of clinical parameters in a patient  with advanced hepatocellular carcinoma   with portal vein thrombosis achieving complete  response after treatment with sorafenib Kwong-Ming Kee1,2 Chao-Hung Hung1,2 Jing-Houng Wang1,2 sheng-Nan Lu1,2 1Division of Hepatogastroenterology,   Department of Internal Medicine,   Kaohsiung Chang Gung Memorial  Hospital, Kaohsiung, Taiwan;  2Chang  Gung University College of Medicine,   Kaohsiung, Taiwan Correspondence: sheng-Nan Lu   123 Ta pei road, Niao-sung District  833,  Kaohsiung City, Taiwan   Tel +886 7 731 7123 ext  8301  Fax +886 7 732 2402  email juten@ms17.hinet.ne tAbstract:  The prognosis is usually poor in advanced hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/62/2f/ott-7-829.PMC4043808.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/62/2f/ott-7-829.PMC4043808.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/2f/ott-7-829.PMC4043808.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/04/ott-7-789.PMC4043809.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 789–798OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  789Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5931 4Positron emission tomographic monitoring   of dual phosphatidylinositol-3-kinase and mTOr  inhibition in anaplastic large cell lymphoma nicolas graf1 Zhoulei li2 Ken herrmann2,4 Daniel Weh2 Michaela aichler3 Jolanta slawska2 axel Walch3 christian Peschel1 Markus schwaiger2 andreas K Buck2,4 T obias Dechow1,* Ulrich Keller1,* 1iii Medical Department, 2Department  of nuclear Medicine, Technische  Universität München, Munich,   germany; 3research Unit analytical  Pathology, helmholtz Zentrum  München, Munich, germany;   4Department of n uclear Medicine,   Universitätsklinikum Würzburg,   Würzburg, germany *These authors contributed equally  to this work correspondence: Ulrich Keller   iii Medical Department, Technische  Universität München, ismaninger  strasse 22, Munich 81675, germany   email ulrich.keller@lrz.tum.d eBackground:  Dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin  (mTOR) inhibition offers an attractive therapeutic strategy in anaplastic large cell lymphoma  depending on oncogenic nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) signaling.",Non-OADS,/arxiv_data1/oa_pdf/52/04/ott-7-789.PMC4043809.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/52/04/ott-7-789.PMC4043809.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/04/ott-7-789.PMC4043809.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHepatic Medicine: Evidence and Research 2014:6 35–43Hepatic Medicine: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  35REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S5777 4Hepatitis C in Argentina: epidemiology   and treatment Luis Alejandro Gaite Sebastián Marciano Omar Andrés Galdame Adrián Carlos Gadano Hepatology Unit, Hospital italiano de  Buenos Aires, Buenos Aires, Argentina Correspondence: Adrián Carlos Gadano   Hepatology Unit, Hospital italiano   de Buenos Aires, 4190 Juan D Perón   Highway, Buenos Aires C1199ABB,   Argentina   Tel +54 11 4959 0200 ext 5370   Fax +54 11 4959 0346   Email adrian.gadano@hospitalitaliano.",Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
"Available  from: http://hepatitisviral.com.ar/presentaciones/reunion21/martes1/ PNS_Hepatitis.pp t. Accessed January 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
"Available from: http://san.org.ar/new/ docs/REGISTRO_ARGENTINO_DE_DIALISIS_CRONICA_2011_ INFORME_COMPLETO.pd f. Accessed April 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
"Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hepatic-medicine-evidence-and-research-journa lHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pedi - atric hepatology in the clinic and laboratory including the following  topics: Pathology, pathophysiology of hepatic disease; Investigation  and treatment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/b4/hmer-6-035.PMC4043810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/sar-5-037.PMC4043811.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpSubstance Abuse and Rehabilitation 2014:5 37–52Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S3725 7emerging drugs of abuse: current perspectives   on substituted cathinones Magalie Paillet-Loilier1 Alexandre Cesbron1 Reynald Le Boisselier2 Joanna Bourgine1 Danièle Debruyne1,2 1Toxicology and Pharmacology  Laboratory, 2Centre  d’evaluation et d’ information  sur la Pharmacodépendance  – Addictovigilance (CeiP-A),   Department of Pharmacology,   University Hospital Centre, Caen,   France Correspondance: Danièle Debruyne   Centre d’evaluation et d’information  sur la Pharmacodépendance –  Addictovigilance (CeiP-A), Department  of Pharmacology, University Hospital  Centre Côte de Nacre, 14033 Caen  cedex 9, France   Tel +33 2 310 646 71   Fax +33 2 310 646 73   email debruyne-d@chu-caen.f rAbstract : Substituted cathinones are synthetic analogs of cathinone that can be considered as  derivatives of phenethylamines with a beta-keto group on the side chain.",Non-OADS,/arxiv_data1/oa_pdf/2c/d2/sar-5-037.PMC4043811.pdf
Available from: http://www.emcdda.europa.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/sar-5-037.PMC4043811.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/2c/d2/sar-5-037.PMC4043811.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/sar-5-037.PMC4043811.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e5/56/tcrm-10-381.PMC4043812.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 381–385Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  381ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S6153 0The impact of intrahepatic cholestasis of  pregnancy with hepatitis B virus infection   on perinatal outcomes Yun hu Yi-ling Ding ling Yu Department of Obstetrics and  gynecology, The second Xiangya  hospital, Central south University,   Changsha, hunan Province, People’s  Republic of China Correspondence: Yi-ling Ding   Department of Obstetrics and  gynecology, The second Xiangya  hospital, Central south University, 139  Renming zhong Road, Changsha 410011,  hunan, People’s Republic of China   Tel/fax +86 0731 85295816   email dingyiling_csu@163.co mIntroduction:  To investigate the impact of intrahepatic cholestasis of pregnancy (ICP) with  hepatitis B virus (HBV) infection on perinatal outcomes.",Non-OADS,/arxiv_data1/oa_pdf/e5/56/tcrm-10-381.PMC4043812.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e5/56/tcrm-10-381.PMC4043812.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e5/56/tcrm-10-381.PMC4043812.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/86/ijwh-6-547.PMC4043813.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 547–554International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  547OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5747 0satisfaction and health-related quality of life  in women with heavy menstrual bleeding;  results from a non-interventional trial of the  levonorgestrel-releasing intrauterine system   or conventional medical therapy ling Xu1 Byung seok lee2 shaheena asif3 Peter Kraemer4 Pirjo Inki5 1Department of gynecology and  Obstetrics, Peking Union Medical  college Hospital, Beijing, People’s  republic of china; 2Department of  Obstetrics and gynecology, Y onsei  University college of Medicine,   gangnam severance Hospital, seoul,   Korea; 3Department of gynaecology  and Obstetrics, surgimed Hospital,   lahore, Pakistan; 4global Medical  affairs excellence and Operations,   5global Medical affairs Women’s  Healthcare, Bayer Healthcare, Berlin,   germany correspondence: Pirjo Inki   Bayer Oy, PO Box 415, FI-20101   Turku, Finland   Tel +358 40 550 1519   Fax +358 20 785 2036   email pirjo.inki@bayer.co mPurpose:  To evaluate the patient satisfaction and health related quality of life (HRQoL) for  levonorgestrel-releasing intrauterine system (LNG-IUS) versus conventional medical  treatments  ([CMTs] combined oral contraceptives, oral progestins, and antifibrinolytics, alone or in   combination ) in Asian women with heavy menstrual bleeding (HMB).",Non-OADS,/arxiv_data1/oa_pdf/a4/86/ijwh-6-547.PMC4043813.pdf
Available from: http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/a4/86/ijwh-6-547.PMC4043813.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a4/86/ijwh-6-547.PMC4043813.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/86/ijwh-6-547.PMC4043813.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 387–394Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  387Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5017 0New treatments for genotype  1 chronic   hepatitis C – focus on simeprevir Tatsuo Kanda Shingo Nakamoto Shuang wu Osamu Y okosuka Department of Gastroenterology   and Nephrology, Graduate School   of Medicine, Chiba University,    Chiba, Japan Correspondence: Tatsuo Kanda   Department of Gastroenterology   and Nephrology, Graduate School   of Medicine, Chiba University,   1-8-1 inohana, Chuo-ku,   Chiba  260-8677, Japan   Tel +81 43 226 2086  Fax +81 43 226 2088  email kandat-cib@umin.ac.j p; kanda2t@ yahoo.co.j pAbstract:  Chronic hepatitis C virus (HCV) infection causes end-stage liver diseases and  hepato cellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0148599 1.,Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
Available from: http://www.hivandhepatitis.com/ hcv-treatment/experimental-hcv-drugs/4367-eacs-2013-simeprevir- with- interferon -effective -for-hivhcv-coinfected-people-with-genotype- 1-or-4 .,Non-OADS,/arxiv_data1/oa_pdf/7b/42/tcrm-10-387.PMC4043814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/e0/tcrm-10-395.PMC4043815.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 395–404Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  395Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4604 1Cabozantinib for progressive metastatic   medullary thyroid cancer: a review Joshua R Colombo Richard O wein Department of Otolaryngology, Head  and Neck Surgery, Tufts Medical  Center, Boston, MA, USA Correspondence: Joshua R Colombo   Department of Otolaryngology, Head   and Neck Surgery, Tufts Medical Center,   800 washington St #850, Boston,   MA 02111, USA   Tel +1 617 636 8711  Fax +1 617 636 1479  email jcolombo@tuftsmedicalcenter.or gAbstract:  Medullary thyroid cancer is uncommon and patients typically present with advanced  disease.",Non-OADS,/arxiv_data1/oa_pdf/99/e0/tcrm-10-395.PMC4043815.pdf
Available from: http://clinicaltrials.gov/show/NCT0163950 8.,Non-OADS,/arxiv_data1/oa_pdf/99/e0/tcrm-10-395.PMC4043815.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/99/e0/tcrm-10-395.PMC4043815.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/e0/tcrm-10-395.PMC4043815.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/37/ott-7-823.PMC4043816.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 823–827OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  823Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6152 4Comprehensive clinical and pathological analysis  of aggressive renal epithelioid angiomyolipoma:  report of three cases Jindan Luo1 Ben Liu1 Yanli Wang2 Jun Li2 Ping Wang1 Jun Chen1 Chaojun Wang1 1Department of Urology,    2Department of Pathology, The  First affiliated Hospital of College  of Medicine, Zhejiang University,   Zhejiang, People’s republic of China Correspondence: Chaojun Wang  Department of Urology, The First  Affiliated Hospital of College of Medicine,  Zhejiang University, No 79 Qingchun  road, Hangzhou, Zhejiang 310003,  People’s republic of China   email wangchaojun_zju@163.co mAbstract:  Renal angiomyolipoma (AML) is recognized as a benign hamartomatous lesion  arising in the kidney with no obvious malignant potential.",Non-OADS,/arxiv_data1/oa_pdf/16/37/ott-7-823.PMC4043816.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/16/37/ott-7-823.PMC4043816.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/37/ott-7-823.PMC4043816.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/92/opth-8-1025.PMC4043817.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1025–1030Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1025Study Pr OtOCO lopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/OPTH.S5992 8Journal name: Clinical Ophthalmology Journal Designation: Study Protocol Y ear: 2014 Volume: 8 Running head verso: Khater et al Running head recto: Argon laser for treatment of resistant infected corneal ulcers DOI: http://dx.doi.org/10.2147/OPTH.S59928 role of argon laser as an adjunctive therapy   for treatment of resistant infected corneal ulcers Mohammad M Khater Adel A Selima Mohammad S El-Shorbagy Ophthalmology department,    tanta university, tanta, EgyptPurpose:  To evaluate the role of argon laser as an adjunctive therapy in ten patients with  resistant infected corneal ulcers with or without hypopyon.",Non-OADS,/arxiv_data1/oa_pdf/62/92/opth-8-1025.PMC4043817.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/62/92/opth-8-1025.PMC4043817.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1030Khater et al Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/62/92/opth-8-1025.PMC4043817.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2014:7 171–183Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  171OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S5985 1Predictability of the individual clinical outcome   of extracorporeal shock wave therapy for cellulite Kai-Uwe schlaudraff1 Maren C Kiessling2 nikolaus BM Császár2 Christoph schmitz2 1Concept Clinic, geneva, switzerland;   2Department of anatomy II, ludwig- Maximilians-University of Munich,   Munich, germany Correspondence: Christoph schmitz   Department of anatomy II,  ludwig-Maximilians-University,  Pettenkoferstrasse, Munich,   80336 germany   Tel +49 892 1807 2620   Fax +49 892 1807 2683   email christoph_schmi tz@med.uni- muenchen.d eBackground:  Extracorporeal shock wave therapy has been successfully introduced for the  treatment of cellulite in recent years.",Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
Available from: http://www.uspto.gov/ trademarks/index.js p. Serial Number 79065686; Registration Number  3712310.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
Available from: http://www.uspto.gov/trademarks/ index.js p. Serial Number 77249758; Registration Number 3593746.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01974115.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/11/ccid-7-171.PMC4043818.pdf
Cells 2014; 37(5): 357-364   http://dx.doi.org/10.14348/molcells.2014.0008        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
Studies from geneti-Molecules and Cells http://molcells.org   Established in 1990,OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
"Cells http://molcells.org     cally engineered mouse models demonstrate that these differ- ent medulloblastoma subtypes likely arise from different cell types within the cerebellum (Gibson et al., 2010; Kawauchi et  al., 2012; Schüller et al., 2008; Yang et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
RNA of Binding Proteins in Medulloblastoma  Rebecca Bish & Christine Vogel      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
Cells http://molcells.org     the growth and survival of medulloblastoma cells was provided  by studies which investigated target mRNAs bound and regu-lated by MSI1.,OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
RNA of Binding Proteins in Medulloblastoma  Rebecca Bish & Christine Vogel      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
"Cells http://molcells.org     licases are currently in various stages of development, mostly  as anti-viral therapies (as RNA helicases often serve as cellular co-factors for viral infections) (Kwong et al., 2005; Lindqvist et  al., 2008; Radi et al., 2012).",Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
RNA of Binding Proteins in Medulloblastoma  Rebecca Bish & Christine Vogel      http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
"Cells http://molcells.org     Fults, D.W., and James, C.D.",OADS,/arxiv_data1/oa_pdf/3f/eb/molcell-37-5-357-1.PMC4044306.pdf
Cells 2014; 37(5): 365-371   http://dx.doi.org/10.14348/molcells.2014.0074   365  Mol.,OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
Cells http://molcells.org       eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
"MACROPHAGES     Macrophages, tissue-resident phagocytes, perform various roles   Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
"Cells http://molcells.org                                                    including scavenging cellular debris derived from apoptotic cells, regulating angiogenesis, and remodeling the extracellular ma- trix (Chawla et al., 2011).",OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
Cells http://molcells.org   HFD-induced dynamic changes in lipid metabolites loaded onto  adipocyte CD1d could mediate functional alterations of iNKT cells in obesity.,Non-OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/15/3c/molcell-37-5-365-2.PMC4044307.pdf
Cells 2014; 37(5): 372-382  http://dx.doi.org/10.14348/molcells.2014.2296        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
"In leptosporangiate ferns, the six complete  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
Cells http://molcells.org     Table 1.,OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
"These repeat sequences were reanalyzed using a DNA pattern  search (http://www.geneinfinity.org /sms/sms_DNApatterns.html#)  for calculating the exact numbers of repeat sequences in the complete cp genome (Kim et al., 2009; Yi et al., 2012).",OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
Cells http://molcells.org      Table 2.,OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
Cells http://molcells.org                                                            Fig.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
Cells http://molcells.org     leptosporangiate fern groups.,OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
"http://tolweb.org/Polypodiopsida/20615/  2009.01.14 in The Tree of Life Web Project, http://tolweb.org/.",OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
"Cells http://molcells.org     S., and Lupia, R. (2004).",OADS,/arxiv_data1/oa_pdf/ec/e6/molcell-37-5-372-3.PMC4044308.pdf
Cells 2014; 37(5): 383-388  http://dx.doi.org/10.14348/molcells.2014.0009        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
MATERIALS AND METHODS    Cell culture and ho nokiol treatment  A-498 cell line was maintained in Dulbecco’s modi ﬁed Eagle’s  Molecules and Cells http://molcells.org   Established in 1990,OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
"Cells http://molcells.org     medium (DMEM, Gibco, USA) supplemented with 10% fetal  bovine serum (FBS) at 37°C with 5% CO 2 in a humidi ﬁed incu- bator.",Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
"Cells http://molcells.org      A B                   C               D                                                                               E                                        We found that honokiol decreased the number of SP cells,  when compared with the control group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
Cells http://molcells.org     ACKNOWLEDGMENTS  This work was supported by Research Project of Guangzhou  Medical University (2013C61).,Non-OADS,/arxiv_data1/oa_pdf/8e/72/molcell-37-5-383-4.PMC4044309.pdf
Cells 2014; 37(5): 389-398  http://dx.doi.org/10.14348/molcells.2014.0032        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
"In zebrafish, two nodal- related genes, squint (sqt/ndr1 )  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
"Cells http://molcells.org     and cyclops  (cyc/ndr2 ) are required for the axial and trunk me- soderm formation as well as endoderm induction (Langdon and Mullins, 2011; Rebagliati et al., 1998).",Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
"Cells http://molcells.org                                                                                   Siah2 overexpression restores lefty-induced mesendo-dermal defects  To ask if the augmented nodal  related genes expression by  Siah2 involves in mesendoderm specification, we co-injected 100 pg of siah2  RNA with 25 pg of atv (lefty1) or lft2 (lefty2 )  RNA.",Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
Cells http://molcells.org                                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
"Cells http://molcells.org     terminal RING domain and interact with proteins targeted for  degradation  via C-terminal domain (Wong and Möller, 2013).",OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
Cells http://molcells.org     phys.,OADS,/arxiv_data1/oa_pdf/49/e1/molcell-37-5-389-5.PMC4044310.pdf
Cells 2014; 37(5): 399-405  http://dx.doi.org/10.14348/molcells.2014.0042        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
"In fact, recent studies suggested that Atg1,  Atg2, and Atg18  are all interconnected and regulate Atg9 traf  Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
"Cells http://molcells.org     fickin in yeast (Zavodszky et al., 2013).",OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
Cells http://molcells.org                              Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
Cells http://molcells.org     structurally weak junction (amino acids 242 to 251 of upper  sequence in Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/1e/6d/molcell-37-5-399-6.PMC4044311.pdf
Cells 2014; 37(5): 406-411  http://dx.doi.org/10.14348/molcells.2014.0072        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
Disruption of hyaluronan  synthase 2  (has2) or versican   in mice and zebrafish is reported to abrogate AVC endocardial  Molecules and Cells http://molcells.org   Established in 1990,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
Cells http://molcells.org                                                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
Cells http://molcells.org                                             Fig.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/7f/28/molcell-37-5-406-7.PMC4044312.pdf
Cells 2014; 37(5): 412-417  http://dx.doi.org/10.14348/molcells.2014.0100        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
"MATERIALS AND METHODS   Reference mRNAs  To obtain a set of unique cDNAs, a database of human mRNA  Molecules and Cells http://molcells.org   Established in 1990",OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
"In order to ensure that the two groups  were not influenced by other fa ctors, other than exo-miRNA TS  proficiency, the  P values for the 3 -UTR length, number of en- do-miRNA TSs, and site proficiency of endo-miRNA 7-8mer  sites were calculated with Wilcoxon’s rank-sum-test using ‘sci-py’ package in Python (http://www.python.org).",OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
Cells http://molcells.org      A  B                            C D                   E F                  G                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
Cells http://molcells.org      A            B          C          Fig.,Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/a1/58/molcell-37-5-412-8.PMC4044313.pdf
Cells 2014; 37(5): 418-425  http://dx.doi.org/10.14348/molcells.2014.0031        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
"MATERIALS AND METHODS   Main reagents The isotonic or hypotonic solution contained (mM): NaCl 95,  KCl 4.5, CaCl 2 1, MgCl 2 1, Hepes 5, D-mannitol 110 or 0 (pH  7.4, adjusted with NaOH, 310 or 200 mOsm/kg H 2O)  Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
Cells http://molcells.org       A B                    C D                   E F                 Fig.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
Cells http://molcells.org      A B             C                 D                                  E                F                        The expression of ClC-3 and ClC-2 mRNA in BMDMs was  examined using RT-PCR.,OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
"Cells http://molcells.org     ible heart-specific ClC-3 knockout mouse found that inactivation  of ClC-3 gene produced myocar dial hypertrophy and heart  failure (Xiong  et al., 2010).",Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/molcell-37-5-418-9.PMC4044314.pdf
Cells 2014; 37(5): 426-434  http://dx.doi.org/10.14348/molcells.2014.2359        eISSN: 0219-1032   The Korean Society for Molecular and Cellular Biology.,OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.",Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
"Numerous autoimmune and neurodegenerative diseases are  associated with citrullination, such as rheumatoid arthritis (RA)  (De Rycke et al., 2005; Foulquier et al., 2007), multiple sclero-sis (Moscarello et al., 2007; Nicholas et al., 2004), Alzheimer  Molecules and Cells http://molcells.org   Established in 1990",Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
Cells http://molcells.org      A                B                              Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
Cells http://molcells.org      A                B                        Fig.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
Cells http://molcells.org     nated vimentin.,OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
http://molcells.org  Mol.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
Cells http://molcells.org     chromatography of peptidylargi nine deiminase from rabbit ske- letal muscle on a column of soybean trypsin inhibitor (Kunitz)- Sepharose.,Non-OADS,/arxiv_data1/oa_pdf/0b/ae/molcell-37-5-426-10.PMC4044315.pdf
"To calculate the max-flow/min-cut on graphs, the public available source code from Yuri Boykov and Vladimir Kolmogorov has been used (http://vision.csd.uwo.ca/code/, Version 3, Date of access: 28/04/2014) 45: Algorithm .The core algorithm has been implemented as own MeVisLab C 11 module and is a combination and extension of the Template-Cut32and the Interactive-Cut28approaches, and the refinement method introduced in29,30.",OADS,/arxiv_data1/oa_pdf/e4/a3/srep05164.PMC4044619.pdf
"Egger, J., Kapur, T. & Viswanathan, A. GYN Data Collection, NCIGT (2012) http://www.spl.harvard.edu/publications/item/view/2227 (Date of access: 28/04/ 2014).",OADS,/arxiv_data1/oa_pdf/e4/a3/srep05164.PMC4044619.pdf
"Zukic ´, D. Spine segmentation and analysis (2013) http://www.cg.informatik.uni- siegen.de/en/spine-segmentation-and-analysis (Date of access: 28/04/2014).",OADS,/arxiv_data1/oa_pdf/e4/a3/srep05164.PMC4044619.pdf
"Fedorov, A., Tuncali, K., Fennessy, F. M. & Tempany, C. M. MR-guided Prostate Biopsy pre- and intra-procedural MRI Registration Evaluation Dataset (2012)http://www.spl.harvard.edu/publications/item/view/2147 (Date of access: 28/04/ 2014).",Non-OADS,/arxiv_data1/oa_pdf/e4/a3/srep05164.PMC4044619.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5164 | DOI: 10.1038/srep05164 7",Non-OADS,/arxiv_data1/oa_pdf/e4/a3/srep05164.PMC4044619.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c4/5b/srep05171.PMC4044620.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5171 | DOI: 10.1038/srep05171 9",Non-OADS,/arxiv_data1/oa_pdf/c4/5b/srep05171.PMC4044620.pdf
"The views and conclusions contained herein are those of the authors andshould not be interpreted as necessarily representing the official policies or endorsements,either expressed or implied of the US government.Additional information Genbank accession numbers KC904971, KF515971-KF515975, KJ708761-KJ708772, KJ776827-KJ776837 Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/a4/c2/srep05113.PMC4044621.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5113 | DOI: 10.1038/srep05113 10",Non-OADS,/arxiv_data1/oa_pdf/a4/c2/srep05113.PMC4044621.pdf
(2004)55(available at http://noc.ac.uk/using-science/ crosswavelet- wavelet-coherence).,Non-OADS,/arxiv_data1/oa_pdf/65/44/srep05159.PMC4044623.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/44/srep05159.PMC4044623.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5159 | DOI: 10.1038/srep05159 7",Non-OADS,/arxiv_data1/oa_pdf/65/44/srep05159.PMC4044623.pdf
"The solvent accessible surface area of the a-subunit of Na,K-ATPase was calculated with the server http://structure.pitt.edu/anchor.",OADS,/arxiv_data1/oa_pdf/0b/77/srep05165.PMC4044624.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5165 | DOI: 10.1038/srep05165 5",Non-OADS,/arxiv_data1/oa_pdf/0b/77/srep05165.PMC4044624.pdf
"In this study, we built classification models to predict the two major histologies of endometrial cancer using whole exome sequencing data, RNA sequencing data, and global copy number data obtained from the TCGA database (http://tcga-data.nci.nih.gov): type I endometrial cancers, i.e., tumors with endometrioid histology, and type II endometrial cancers, i.e., tumors with serous histology.",OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
"Microscopy imaging data .Three available histological images of mixed-type endometrial cancer (TCGA-AX-A1CR, TCGA-BK-A0CA, and TCGA-D1-A0ZZ) were obtained from Berkeley Cancer Morphometric Data (http://tcga.lbl.gov/biosig/ tcgadownload.do).",OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
"Int J Cancer 127, 2893–2917, doi:http://dx.doi.org/10.1002/ijc.25516 (2010).",Non-OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
"Obstet Gynecol 120, 383–397, doi:http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
"Virchows Arch 462, 289–296, doi:http://dx.doi.org/10.1007/s00428-013-1382-8 (2013).",Non-OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5174 | DOI: 10.1038/srep05174 8",Non-OADS,/arxiv_data1/oa_pdf/97/f3/srep05174.PMC4044625.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/7f/srep05169.PMC4044626.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5169 | DOI: 10.1038/srep05169 8",Non-OADS,/arxiv_data1/oa_pdf/18/7f/srep05169.PMC4044626.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/e8/srep05128.PMC4044635.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5128 | DOI: 10.1038/srep05128 7",Non-OADS,/arxiv_data1/oa_pdf/f7/e8/srep05128.PMC4044635.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/srep05161.PMC4044637.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5161 | DOI: 10.1038/srep05161 6",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/srep05161.PMC4044637.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5121 | DOI: 10.1038/srep05121 6",Non-OADS,/arxiv_data1/oa_pdf/46/7c/srep05121.PMC4044638.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/73/srep05168.PMC4044652.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5168 | DOI: 10.1038/srep05168 6",Non-OADS,/arxiv_data1/oa_pdf/02/73/srep05168.PMC4044652.pdf
"T o view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experiment al & Molecular Medicine website (http://www.nature.com/emm)Oncogenic mechanism of KIF14 in HCC HX u et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/55/02/emm201423a.PMC4044675.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Experiment al & Molecular Medicine website (http://www.nature.com/emm)Betacellulin enhances islets engraftment M-Y Song et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/f6/b1/emm201424a.PMC4044676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Zn(II)-curc degrades mutp53 through autophagy A Garuﬁ et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ef/c8/cddis2014217a.PMC4044866.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50681 | Page 1 of 27Video Article Using an Automated 3D-tracking System to Record Individual and Shoals of Adult Zebrafish Hans Maaswinkel1, Liqun Zhu1, Wei Weng1 1R&D, xyZfish Correspondence to: Hans Maaswinkel at hmaaswinkel@xyzfish.com URL: http://www.jove.com/video/50681 DOI: doi:10.3791/50681 Keywords: Behavior, Issue 82, neuroscience, Zebrafish, Danio rerio , anxiety, Shoaling, Pharmacology, 3D-tracking, MK801 Date Published: 12/5/2013 Citation: Maaswinkel, H., Zhu, L., Weng, W. Using an Automated 3D-tracking System to Record Individual and Shoals of Adult Zebrafish.",Non-OADS,/arxiv_data1/oa_pdf/0f/fc/jove-82-50681.PMC4044921.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50681/ Introduction Zebrafish has become an important model for biological and pharmacological research1-3.,Non-OADS,/arxiv_data1/oa_pdf/0f/fc/jove-82-50681.PMC4044921.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50560 | Page 1 of 11Video Article Microfluidic Picoliter Bioreactor for Microbial Single-cell Analysis: Fabrication, System Setup, and Operation Alexander Gruenberger1, Christopher Probst1, Antonia Heyer1, Wolfgang Wiechert1, Julia Frunzke1, Dietrich Kohlheyer1 1Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Juelich GmbH Correspondence to: Dietrich Kohlheyer at d.kohlheyer@fz-juelich.de URL: http://www.jove.com/video/50560 DOI: doi:10.3791/50560 Keywords: Bioengineering, Issue 82, Soft lithography, SU-8 lithography, Picoliter bioreactor, Single-cell analysis, Polydimethylsiloxane, Corynebacterium glutamicum , Escherichia coli , Microfluidics, Lab-on-a-chip Date Published: 12/6/2013 Citation: Gruenberger, A., Probst, C., Heyer, A., Wiechert, W., Frunzke, J., Kohlheyer, D. Microfluidic Picoliter Bioreactor for Microbial Single-cell Analysis: Fabrication, System Setup, and Operation.",Non-OADS,/arxiv_data1/oa_pdf/4b/9b/jove-82-50560.PMC4044959.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50560/ Introduction Time-lapse microscopy is a powerful tool for studying living cells in vivo1.,Non-OADS,/arxiv_data1/oa_pdf/4b/9b/jove-82-50560.PMC4044959.pdf
http://dx.doi.org/10.1039/C2LC40156H .,Non-OADS,/arxiv_data1/oa_pdf/4b/9b/jove-82-50560.PMC4044959.pdf
(A) Growth plot of three PLBR cultivations and resulting exponential curves (Parts reproduced with permission of the Royal Society of Chemistry)13. http://dx.doi.org/10.1039/C2LC40156H .,OADS,/arxiv_data1/oa_pdf/4b/9b/jove-82-50560.PMC4044959.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseDecember 2013 |  82  | e50856 | Page 1 of 8Video Article Enrichment and Purging of Human Embryonic Stem Cells by Detection of Cell Surface Antigens Using the Monoclonal Antibodies TG30 and GCTM-2 Juan Carlos Polanco1, Bei Wang1, Qi Zhou1, Hun Chy1, Carmel O'Brien1, Andrew L. Laslett1 1Materials Science and Engineering, CSIRO Correspondence to: Andrew L. Laslett at andrew.laslett@csiro.au URL: http://www.jove.com/video/50856 DOI: doi:10.3791/50856 Keywords: Stem Cell Biology, Issue 82, Stem cells, cell surface antigens, antibodies, FACS, purging stem cells, differentiation, pluripotency, teratoma, human embryonic stem cells (hESC) Date Published: 12/6/2013 Citation: Polanco, J.C., Wang, B., Zhou, Q., Chy, H., O'Brien, C., Laslett, A.L.",Non-OADS,/arxiv_data1/oa_pdf/10/be/jove-82-50856.PMC4044978.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50856/ Introduction HPSC (hPSC) include human embryonic stem cells (hESC) and human induced pluripotent stem cells (hIPSC).,Non-OADS,/arxiv_data1/oa_pdf/10/be/jove-82-50856.PMC4044978.pdf
( http://www.wicell.org/home/support/stem-cell-protocols/stem-cell- protocols.cmsx ) (2013).,Non-OADS,/arxiv_data1/oa_pdf/10/be/jove-82-50856.PMC4044978.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/dddt-8-601.PMC4044992.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 601–607Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  601Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6310 0shih-lung cheng1,2 Kang-cheng su3 hao-chien Wang4,* Diahn-Warng Perng3,* Pan-chyr Yang4 1Department of internal Medicine,   Far eastern Memorial hospital,   new Taipei city, 2Department of  chemical engineering and Materials  science, Yuan Ze University, Zhongli  city, Taoyuan county,  3Department  of chest Medicine, Taipei Veterans  general hospital, Taipei,  4Department  of internal Medicine, national Taiwan  University hospital, Taipei, Taiwan *These authors contributed equally to  this work correspondence: hao-chien Wang;  Diahn-Warng Perng   Department of internal Medicine,  national Taiwan University hospital,   7 Zhongshan south road, Zhongzheng,  Taipei  100, Taiwan   Tel +886 2 2312 3456 ext  2905  Fax +886 2 2358 2867  email haochienwang@gmail.co m;  dwperng@vghtpe.gov.t wPurpose:  Complications of pneumonia development in patients with chronic  obstructive  pulmonary disease (COPD) receiving inhaled corticosteroid (ICS) therapy have been   documented.",Non-OADS,/arxiv_data1/oa_pdf/bb/a0/dddt-8-601.PMC4044992.pdf
"Available from: http://www.goldcopd.org/uploads/users/ files/GOLD_Report_2013_Feb20.pd f. Accessed April  12, 2014.",OADS,/arxiv_data1/oa_pdf/bb/a0/dddt-8-601.PMC4044992.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/bb/a0/dddt-8-601.PMC4044992.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/a0/dddt-8-601.PMC4044992.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6d/2c/ijn-9-2713.PMC4044993.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2713–2725International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2713RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5594 3Multifunctional materials for bone   cancer treatment Catarina Marques1 José MF Ferreira1 ecaterina Andronescu2 Denisa Ficai2 Maria Sonmez3 Anton Ficai2 1Department of Materials and  Ceramics engineering, Centre for  Research in Ceramics and Composite  Materials , University of Aveiro,   Aveiro, Portugal; 2Faculty of Applied  Chemistry and Material Science,   University Politehnica of Bucharest,   Bucharest, Romania; 3National  Research and Development Institute  for T extiles and Leather, Bucharest,   Romania Correspondence: Anton Ficai   Faculty of Applied Chemistry and  Material Science, University Politehnica of  Bucharest, 1–7 Polizu Street, Bucharest  011061, Romania   email anton.ficai@upb.r oAbstract:  The purpose of this review is to present the most recent findings in bone tissue  engineering.",Non-OADS,/arxiv_data1/oa_pdf/6d/2c/ijn-9-2713.PMC4044993.pdf
"Available from: http://www.cancerresearchuk.org/cancer ­info/  cancerstats/world/the­global­pictur e. Accessed January 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/6d/2c/ijn-9-2713.PMC4044993.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer ­ reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/6d/2c/ijn-9-2713.PMC4044993.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6d/2c/ijn-9-2713.PMC4044993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/43/9e/dddt-8-627.PMC4044994.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 627–637Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  627Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6308 8anxiolytic and antidepressant-like activities   of the novel and potent non-imidazole   histamine h3 receptor antagonist sT -1283 amine Bahi1,* Johannes stephan schwed2,3 Miriam Walter2 holger stark3 Bassem sadek4,* 1Department of anatomy, college   of Medicine and health sciences,   United arab emirates University,    al ain, United arab emirates;    2institut für Pharmazeutische chemie,   Biozentrum, Johann Wolfgang goethe  University, Frankfurt, 3heinrich heine  University Duesseldorf, institut fuer  Pharmazeutische and Medizinische  chemie, Düsseldorf, germany;   4Department of Pharmacology and  Therapeutics, college of Medicine  and health sciences, United arab  emirates University, al ain, United  arab emirates *These authors contributed equally   to this work correspondence: amine Bahi   Department of anatomy,   college of Medicine and health   sciences, United arab emirates  University, PO Box  17666, al ain,   United arab emirates   Tel +97 13 713 7516  Fax +97 13 767 2033  email amine.bahi@uaeu.ac.a e    Bassem sadek   Department of Pharmacology,   college of Medicine and health   sciences, United arab emirates  University, PO Box  17666, al ain,   United arab emirates   Tel +97 13 713 7512  Fax +97 13 767 2033  email bassem.sadek@uaeu.ac.a eAbstract:  Previous studies have suggested a potential link between histamine H3 receptors  (H3R) signaling and anxiolytic-like and antidepressant-like effects.",Non-OADS,/arxiv_data1/oa_pdf/43/9e/dddt-8-627.PMC4044994.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/43/9e/dddt-8-627.PMC4044994.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/9e/dddt-8-627.PMC4044994.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/dddt-8-639.PMC4044995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 639–650Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  639Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/DDDT .S6202 4neurotherapeutic activity of the recombinant  heat shock protein hsp70 in a model of focal  cerebral ischemia in rats Maxim a shevtsov1,2 Boris P nikolaev3 ludmila Y Yakovleva3 anatolii V Dobrodumov4 anastasiy s Dayneko5 alexey a shmonin5,6 Timur D Vlasov5 elena V Melnikova5 alexander D Vilisov4,5 irina V guzhova1 alexander M ischenko3 anastasiya l Mikhrina7 Oleg V galibin5 igor V Yakovenko2 Boris a Margulis1 1institute of cytology of the russian  academy of sciences ( ras), st  Petersburg, russia;  2al Polenov  russian research scientific institute  of neurosurgery, st Petersburg,   russia;  3research institute of highly  Pure Biopreparations, st Petersburg,   russia;  4institute of Macromolecular  compounds of the russian academy  of sciences (ras), st Petersburg,   russia;  5First st Petersburg iP   Pavlov state Medical University,    st Petersburg, russia;  6Federal  almazov Medical research centre,   st Petersburg, russia; 7iM sechenov  institute of evolutionary Physiology  and Biochemistry of the russian  academy of sciences (ras),    st Petersburg, russia correspondence: Maxim a shevtsov   institute of cytology (ras),  194064  Tikhoretsky ave  4, st Petersburg, russia   Tel +7 812 297 7450  Fax +7 812 297 0341  email shevtsov-max@mail.r uAbstract:  Recombinant  70 kDa heat shock protein (Hsp70) is an antiapoptotic protein that  has a cell protective activity in stress stimuli and thus could be a useful therapeutic agent in the  management of patients with acute ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/5d/29/dddt-8-639.PMC4044995.pdf
"The open source  software package R (v  3.0.2 [ http://www.r-project.org /]; The  R Foundation for Statistical Computing, Vienna, Austria)  was used for statistical analysis.",OADS,/arxiv_data1/oa_pdf/5d/29/dddt-8-639.PMC4044995.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5d/29/dddt-8-639.PMC4044995.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/29/dddt-8-639.PMC4044995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/dd/copd-9-563.PMC4044996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 563–568International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  563OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5996 2Prevalence of airflow limitation in outpatients  with cardiovascular diseases in Japan Katsuya Onishi1 Daisuke Y oshimoto2 gerry W hagan3 Paul W Jones4 1Onishi heart Clinic, Mie, 2Medical  affairs respiratory, glaxosmithKline  KK, T okyo, Japan; 3Independent  Consultant, Marbella, spain; 4Division  of Clinical science, st george’s,   University of london, london, UK Correspondence: Katsuya Onishi   Onishi heart Clinic, 3431-5 handa,   Tsu, Mie 514-0823, Japan   Tel +81 59 225 2597   Fax +81 59 225 3033   email katsu0812@way.ocn.ne.j pBackground and objectives:  Cardiovascular disease (CVD) and chronic obstructive   pulmonary disease (COPD) commonly coexist and share common risk factors.",Non-OADS,/arxiv_data1/oa_pdf/1a/dd/copd-9-563.PMC4044996.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1a/dd/copd-9-563.PMC4044996.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/dd/copd-9-563.PMC4044996.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/1a/dd/copd-9-563.PMC4044996.pdf
http://dx.doi.org/ 10.1038/nrc2888 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
1:375– 404. http://dx.doi.org/ 10.1146/annurev.pathol.1.110304.100209 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1099/0022-1317-73-12 -3275 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1084/jem.20020890 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1093/infdis/174.5.1101 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1126/science.7725108 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1126/ science.1096781 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1038/nmeth746 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/j.cell.2009.01.002 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1371/journal.ppat.1003018 .Role of miRNAs in Gammaherpesvirus Pathogenesis May/June 2014 Volume 5 Issue 3 e00981-14®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/j.virol.2011.01.002 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1101/ gad.17352611 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/j.coviro.2013.05.013 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1261/rna.2326106 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1128/JVI.79.14.9301-9305.2005 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/j.chom.2010.03.008 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002484 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/ journal.ppat.1002884 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.3390/v4091687 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1038/nature05992 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/ JVI.05558-11 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1126/science.1187197 .32.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1146/annurev-immunol-072710-081639 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/journal.pone.0047863 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1261/rna.1873910 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/journal.pone.0047863 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1093/nar/gkq1027 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.02689-07 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.02572 -09.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.01455-10 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1093/nar/gkg595 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.77.4.2522-2529.2003 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.4049/jimmunol.164.11.5729 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1099/vir.0.013300-0 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/ JVI.76.14.7125-7132.2002 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1084/jem.20011825 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1038/nm1297-1346 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1152/ajplung.00007.2005 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1158/0008-5472.CAN-09-0291 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.00989-09 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.01313-07 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/j.molcel.2008.10.013 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1038/nature08349 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.02013-09 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1016/ j.cell.2012.04.005 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1056/NEJMra032015 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1128/JVI.77.17.9700-9709.2003 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/journal.ppat.1001305 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
195: 645– 659. http://dx.doi.org/10.1086/511434 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1371/journal.ppat.1003484 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.02104-08 .,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1093/nar/ gkq1043 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1038/ embor.2010.132 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1128/JVI.74.16.7451-7461.2000 .,OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/10.1172/JCI14358 .Role of miRNAs in Gammaherpesvirus Pathogenesis May/June 2014 Volume 5 Issue 3 e00981-14®mbio.asm.org 15,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/mBio.00981-14.PMC4045068.pdf
http://dx.doi.org/ 10.1128/mBio.00898-13 .,Non-OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
4:e3.http://dx.doi.org/ 10.1371/journal.pbio.0040003 .,Non-OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
http://dx.doi.org/ 10.1016/0042-6822(74)90300-6 .,OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
36:455– 461. http://dx.doi.org/10.1071/ AP07050 .,Non-OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
http://dx.doi.org/10.1128/JCM.06717-11 .,Non-OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
"This Week in Virology, episode 271. http://www.twiv.tv/2014/ 02/09/twiv-271-to-bee-or-not-to-bee-that-is-the-infection/ .",Non-OADS,/arxiv_data1/oa_pdf/f1/a0/mBio.00985-14.PMC4045069.pdf
All ﬁtness data are available in MicrobesOnline ( http://microbesonline.org/ ).,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
Nature 296: 643– 645. http://dx.doi.org/ 10.1038/296643a0 .,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1111/j.1574-6941.2009.00709.x .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
6:441– 454. http://dx.doi.org/ 10.1038/nrmicro1892 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1023/A:1008307929134 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1016/j.jhazmat.2008.11.088 .,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
Lang-muir 27:6449 – 6457. http://dx.doi.org/10.1021/la200141t .,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
193:4268 – 4269. http://dx.doi.org/10.1128/JB.05400-11 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/AEM.05495 -11.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/ AEM.01839-09 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1093/nar/gkl146 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/JB.01913-06 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
191:4924 – 4933. http://dx.doi.org/10.1128/JB.00197-09 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
16:1– 8. http://dx.doi.org/10.1111/1462-2920.12273 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1021/pr070127o .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/ JB.01977-12 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1093/ nar/gkq089 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1186/gb-2004-5 -11-r90 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1128/JB.01959-12 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
73:6305– 6312. http://dx.doi.org/10.1128/AEM.00715 -07.,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1099/mic.0.051284-0 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/AEM.00691-10 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
191:4158 – 4165. http://dx.doi.org/10.1128/ JB.00416-09 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1126/ science.1160446 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/JB.05563-11 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1186/gb-2011-12-10-r99 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1111/j.1462-2920.2010.02234.x .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/JB.01764-07 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1371/journal.pgen.1002385 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
Biol.9:674. http://dx.doi.org/10.1038/msb.2013.30 .,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
73:594 – 651. http://dx.doi.org/10.1128/MMBR.00024-09 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/JB.00085-09 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
396:800 – 820. http://dx.doi.org/ 10.1016/j.jmb.2009.12.012 .,OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1074/jbc.M113.455402 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
424: 467– 478. http://dx.doi.org/10.1042/BJ20090999 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
182: 4862– 4867. http://dx.doi.org/10.1128/ JB.182.17.4862-4867.2000 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1128/JB.02179-12 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1111/j.1365-2958.2007.05608.x .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
188: 4068 – 4078. http://dx.doi.org/10.1128/JB.01921-05 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1093/nar/gkq419 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1007/s00203-002-0442-2 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/ 10.1128/JB.185.19.5673-5684.2003 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1126/science.1176951 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1093/bioinformatics/15.7.563 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
195: 4900 – 4914. http://dx.doi.org/10.1128/JB.00504-13 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1038/ nprot.2007.427 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
80:855– 868. http://dx.doi.org/ 10.1128/AEM.02963-13 .,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
http://dx.doi.org/10.1093/nar/29.1.123 .Desulfovibrio alaskensis G20 Transposon Collection May/June 2014 Volume 5 Issue 3 e01041-14®mbio.asm.org 13,Non-OADS,/arxiv_data1/oa_pdf/21/b9/mBio.01041-14.PMC4045070.pdf
"The coding sequences of iraL andiraM were queried against complete bacterial genomes in the NCBI database ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ), and several unsequenced strain collections were subjected to a PCR-based assay foriraL andiraM .",OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
57:441– 466. http://dx.doi.org/10.1146/annurev.micro.57.030502.090913 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1128/JB.187.5.1591 -1603.2005 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1146/annurev-micro-090110-102946 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1101/ gad.229617.113 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1111/j.1365-2958.2008.06146.x .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1111/jam.12021 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1007/s00438-007-0311-4 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
BMC Genomics 10:349. http://dx.doi.org/10.1186/1471-2164-10-349 .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
78:887– 897. http://dx.doi.org/10.1128/IAI.00882-09 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1128/ mBio.00023-13 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1128/JB.187.3.1135-1160.2005 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/ 10.1101/sqb.1998.63.141 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1086/ 315217 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1073/ pnas.95.10.5752 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1016/j.ymeth.2012.07.018 .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
1:e00988- 13. http://dx.doi.org/10.1128/genomeA.00988-13 .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
77: 6630 – 6635. http://dx.doi.org/10.1128/AEM.05307-11 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/ 10.1016/j.gene.2006.04.018 .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1016/0378 -1119(91)90604-A .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1128/JB.01598-12 .,Non-OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1016/0003 -2697(76)90527-3 .,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/10.1002/ pmic.200500404 .Hryckowian et al.,OADS,/arxiv_data1/oa_pdf/18/3d/mBio.01043-14.PMC4045071.pdf
http://dx.doi.org/ 10.1038/ja.2009.117 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1016/ j.ccc.2007.12.005 .,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
50:4114 – 4123. http://dx.doi.org/10.1128/AAC.00778-06 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1097/01.ta.0000241143.71274.63 .6.Tong MJ.,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1001/jama.219.8.1044 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/ 10.1128/AAC.05124-11 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
42:479 – 483. http://dx.doi.org/10.3109/00365541003671226 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1086/ 653617 .,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1371/ journal.pone.0030673 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1016/ j.jinf.2009.09.004 .,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
21:601– 614. http://dx.doi.org/10.1101/ gad.1510307 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1099/mic.0.26541-0 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/JB.01416-07 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/JCM.01264-09 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/IAI.00269-08 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
190: 8053– 8064. http://dx.doi.org/10.1128/JB.00834-08 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
13: 807– 815. http://dx.doi.org/10.1111/j.1469-0691.2007.01759.x .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1016/B978-0 -12-394805-2.00002-6 .,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/AAC.01533-08 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1371/journal.pone.0022674 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/IAI.06279-11 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/ AAC.01944-13 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1128/AEM.02882-07 .,Non-OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
http://dx.doi.org/10.1016/ j.mimet.2010.07.002 .Jacobs et al.,OADS,/arxiv_data1/oa_pdf/ea/b1/mBio.01076-14.PMC4045072.pdf
Se-quences were analyzed using the RDP pipeline (http://rdp.cme.msu.edu/)and sequences matching the intracellular symbiont Wolbachia sp.,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1128/IAI.01496-06 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/ 10.1371/journal.pgen.1002272 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1128/AEM.02120 -06.,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1126/science.1149357 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1111/j.1462-2920.2011.02511.x .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1128/mBio.00860-13 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1371/journal.pone.0070749 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.4161/ gmic.19896 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/0022-2011(69)90163-3 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1371/ journal.pone.0036765 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
14:403– 414. http://dx.doi.org/10.1016/j.cmet.2011.07.012 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1128/ AEM.02742-13 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/ 10.1101/gad.1827009 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/j.cmet.2007.06.006 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1038/ismej.2013.86 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/ j.chom.2008.07.004 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/0047-6374(72)90054-1 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/ 10.1080/09553007314550031 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
Cell Stem Cell 3:442– 455. http://dx.doi.org/10.1016/j.stem.2008.07.024 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1371/ journal.pgen.1001159 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1111/j.1474 -9726.2008.00380.x .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/j.immuni.2011.09.018 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/S1074-7613(00)00072-8 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.7554/eLife.00886.001 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/j.cell.2013.12.018 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
"http://dx.doi.org/10.1038/nrg1989 .32.Buchon N, Broderick NA, Kuraishi T, Lemaitre B.",Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
8:152. http://dx.doi.org/10.1186/1741 -7007-8-152 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
Development 138: 4585– 4595. http://dx.doi.org/ 10.1242/dev.065292 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1016/ j.bbagen.2012.08.009 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
Cell 156:69 – 83. http://dx.doi.org/10.1016/ j.cell.2013.12.008 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1111/j.1574 -6976.2008.00123.x .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
Genesis 48: 607– 611. http://dx.doi.org/10.1002/dvg.20661 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1038/35046087 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
doi: http://dx.doi.org/10.1007/978-1-59745-570-1_22 .,Non-OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
Cell 5:441– 450. http://dx.doi.org/10.1016/ S1534-5807(03)00244-2 .,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1128/AEM.70.1.293-300.2004 .Host-Microbiota Interactions in D. melanogaster May/June 2014 Volume 5 Issue 3 e01117-14®mbio.asm.org 13,OADS,/arxiv_data1/oa_pdf/29/e9/mBio.01117-14.PMC4045073.pdf
http://dx.doi.org/10.1099/13500872-145-3 -519 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1038/327532a0 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1128/JCM.06192-11 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1038/ nmeth996 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/ 10.1016/S0076-6879(06)21015-2 .,OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1371/journal.ppat.1002511 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1016/j.chembiol.2011.12.016 .,OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1099/00221287 -143-7-2267 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1038/nm765 .,OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
48: 77– 84. http://dx.doi.org/10.1046/j.1365-2958.2003.03425.x .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1038/2417 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1016/j.ab.2009.01.015 .,OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/ 10.1371/journal.pone.0026750 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1016/ j.tube.2008.07.007 .,OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1101/gad.13.7.901 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1128/JB.00332-07 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1111/ j.1365-2958.2010.07463.x .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1038/ nature00935 .,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
http://dx.doi.org/10.1016/S0076-6879(10)70007-0 .Recombineering-Enhanced Transduction in M.tuberculosis May/June 2014 Volume 5 Issue 3 e01179-14®mbio.asm.org 7,Non-OADS,/arxiv_data1/oa_pdf/98/79/mBio.01179-14.PMC4045075.pdf
"Signiﬁ-cant hits were roughly aligned using MAFFT ( http://mafft.cbrc.jp/ alignment/software/ ), and the PBP2/3 or PBP1a/b/c clusters were selected for a full alignment in MAFFT.",OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
LDT homologs were gathered on the basisof the ykud Pfam domain ( http://pfam.sanger.ac.uk ) and then aligned FIG 7 Model of A. tumefaciens cell growth dynamics and major protein localization over the cell cycle.,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
Columns containing more than 75% gaps were removed using trimAl ( http://trimal.cgenomics.org ).,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
"PhyML ( http://www.atgc -montpellier.fr/phyml/ ) was used to calculate maximum-likelihood trees, using aLRT SH-like estimates of branch support.",OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
"Trees were visualizedusing Archaeopteryx (version 0.9813; Christian Zmasek, Sanford- Burnham Medical Research Institute [ http://www.phyloxml.org ]) and Adobe Illustrator CS6 (Adobe Systems).",OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
Demographs were con- structed by ﬁrst measuring ﬂuorescence intensity proﬁles in Fiji and thenprocessing the data in R (version 3.0.2; R Foundation for Statistical Com-puting [ http://www.r-project.org ]) using a custom script designed to sort cells by length and normalize intensity proﬁles by each cell’s average ﬂu-orescence.,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
The script and a user guide are available at http://github.com/ ta-cameron/Cell-Proﬁles .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
"Demographs and all other plotted ﬁgures were generated in R using the ggplot2 package (version 0.9.3.1; Hadley Wick-ham, Department of Statistics, Rice University [ http://ggplot2.org ]).",OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
88:664 – 672. http://dx.doi.org/10.1111/mmi.12203 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1073/ pnas.1117132109 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
18:59 – 66. http://dx.doi.org/ 10.1016/j.tim.2009.12.004 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1016/S0006-3495(00)76726-9 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1099/00221287-136-12-2521 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1574-6976.2007.00090.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1016/j.bbamem.2007.06.007 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1126/ science.1239248 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1038/emboj.2009.277 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1016/j.cub.2009.06.033 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
67:417– 435. http://dx.doi.org/10.1146/annurev-micro-092412 -155622 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1016/S0092-8674(01)00287-2 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/ 10.1073/pnas.0810794106 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1073/ pnas.1307241110 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/mmi.12150 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/JB.00260-12 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/JB.00720-07 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.01949.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1146/ annurev.micro.112408.134102 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
190: 4782– 4785. http://dx.doi.org/10.1128/ JB.00025-08 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1007/ s00438-010-0542-7 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
24:79 – 88. http://dx.doi.org/10.1038/nbt1172 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
193:4984 – 4987. http://dx.doi.org/10.1128/JB.00315-11 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1126/ science.1178123 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1038/ emboj.2011.246 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1002/ anie.201206749 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2011.07677.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1365-2958.2009.06706.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1365-2958.2005.04522.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
187: 54 – 64. http://dx.doi.org/ 10.1128/JB.187.1.54-64.2005 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
74: 650 – 661. http://dx.doi.org/10.1111/j.1365-2958.2009.06887.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
190: 4360 – 4366. http://dx.doi.org/10.1128/JB.00239-08 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/JB.183.10.3065 -3075.2001 .,OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
73: 586 – 600. http://dx.doi.org/10.1111/j.1365-2958.2009.06794.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1038/ sj.emboj.7601577 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2012.08064.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1371/ journal.pone.0056682 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/ mmi.12347 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1099/ mic.0.2006/001362-0 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1046/ j.1365-2958.2001.02499.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/ JB.00476-06 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/ JB.00415-07 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
193:4973– 4983. http://dx.doi.org/10.1128/JB.00316-11 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1111/j.1365 -2958.2012.08138.x .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/ 10.1128/AEM.01098-08 .,Non-OADS,/arxiv_data1/oa_pdf/75/56/mBio.01219-14.PMC4045076.pdf
http://dx.doi.org/10.1128/mBio.00985-14 .,Non-OADS,/arxiv_data1/oa_pdf/10/79/mBio.01250-14.PMC4045077.pdf
http://dx.doi.org/ 10.1128/mBio.00898-13 .Author Reply 2®mbio.asm.org May/June 2014 Volume 5 Issue 3 e01250-14,Non-OADS,/arxiv_data1/oa_pdf/10/79/mBio.01250-14.PMC4045077.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/23/ijn-9-2753.PMC4045085.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2753–2765International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2753OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S60624Mussel-inspired human gelatin nanocoating   for creating biologically adhesive surfaces Xi Yang1,2 liping Zhu1 seiichi Tada1 Di Zhou3 Takashi Kitajima1 Takashi Isoshima1 Yasuhiro Y oshida1,4 Mariko Nakamura1,5 Weiqun Yan2 Y oshihiro Ito1,3 1Nano Medical engineering  laboratory, rIKeN, saitama,    Japan;  2school of Pharmaceutical   sciences, Jilin University, Jilin,    People’s republic of china;    3emergent Bioengineering Materials   research Team, rIKeN center for   emergent Matter science, saitama,    4Department of Biomaterials and  Bioengineering, graduate school of  Dental Medicine, hokkaido University,   hokkaido , 5Dental hygiene   Program, Kibi International   college, Okayama, Japan correspondence: Yoshihiro Ito   Nano Medical engineering laboratory,   rIKeN,  2-1 hirosawa, Wako-shi,   saitama  351-0198, Japan   email y-ito@riken.j pAbstract:  Recombinant human gelatin was conjugated with dopamine using carbodiimide as a  surface modifier.",Non-OADS,/arxiv_data1/oa_pdf/62/23/ijn-9-2753.PMC4045085.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/62/23/ijn-9-2753.PMC4045085.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/23/ijn-9-2753.PMC4045085.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/28/ijn-9-2741.PMC4045086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 2741–2751International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2741OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5933 8Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Zhang et al Running head recto: N3-O-toluyl-fluorouracil nanosuspensions in H22-bearing mice DOI: http://dx.doi.org/10.2147/IJN.S59338 Preclinical studies of N3-O-toluyl-fluorouracil- loaded lipid-based nanosuspensions   in h22-bearing mice Juan Zhang Min li Zhihong liu lili Wang Y ongjun liu Na Zhang school of Pharmaceutical science,   shandong University, Ji’nan, People’s  republic of china correspondence: Na Zhang   school of Pharmaceutical science,  shandong University, 44 Wenhua Xi  road, Ji’nan 250012, People’s republic  of china   Tel +86 531 8838 2015   Fax +86 531 8838 2548   email zhangnancy9@sdu.edu.c nPurpose:  N3-O-toluyl-fluorouracil (TFU) is a potential antitumor prodrug of 5-fluorouracil  (5-FU), but its poor solubility has limited its use in clinic.",Non-OADS,/arxiv_data1/oa_pdf/a6/28/ijn-9-2741.PMC4045086.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a6/28/ijn-9-2741.PMC4045086.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 2751N3-O-toluyl-fluorouracil nanosuspensions in H22-bearing mice  5.,Non-OADS,/arxiv_data1/oa_pdf/a6/28/ijn-9-2741.PMC4045086.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813002409 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1a/40/S0950268813002409a.PMC4045166.pdf
Reported tuberculosis in the United States (http://www.cdc.gov/tb/statistics/reports/2011/pdf/report2011.pdf).,Non-OADS,/arxiv_data1/oa_pdf/1a/40/S0950268813002409a.PMC4045166.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813002094 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution licen ce <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/S0950268813002094a.PMC4045167.pdf
Hunting statistics database (https://www.viltdata.,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/S0950268813002094a.PMC4045167.pdf
National animal health database (https://www.jordbruksverket.se).,OADS,/arxiv_data1/oa_pdf/1d/1a/S0950268813002094a.PMC4045167.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001726 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/26/59/S0950268813001726a.PMC4045170.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001866 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution licen ce <http://creativecommons.org/licenses/by-nc-sa/3.0/>,Non-OADS,/arxiv_data1/oa_pdf/43/2a/S0950268813001866a.PMC4045171.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813001866.,Non-OADS,/arxiv_data1/oa_pdf/43/2a/S0950268813001866a.PMC4045171.pdf
(http://www.searo.,Non-OADS,/arxiv_data1/oa_pdf/43/2a/S0950268813001866a.PMC4045171.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/8f/ijwh-6-565.PMC4045174.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 565–572International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  565OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S6070 9Key determinants of induced abortion in women  seeking pos tabortion care in hospital facilities   in Ouagadougou, Burkina Faso Patrick gc Ilboudo1–3 serge M a somda4 Johanne sundby3 1Département de santé Publique,   Unité de recherche sur les Politiques  et systèmes de santé, centre  Muraz, Bobo-Dioulasso, Burkina  Faso; 2agence de Formation, de  recherche et d’expertise en santé  pour l’afrique (aFrIcsanté), Bobo- Dioulasso, Burkina Faso;  3Department  of community Medicine, University  of Oslo, Oslo, norway;  4Département  des Maladies non Transmissibles,   Unité de Formation et d’ appui  Méthodologique, centre Muraz, Bobo- Dioulasso, Burkina Faso correspondence: Patrick gc Ilboudo   Département de santé Publique, Unité de  recherche sur les Politiques et systèmes  de santé, centre Muraz, 2054 avenue  Mamadou Konaté, 01 BP 390 Bobo- Dioulasso, Burkina Faso   Tel +226 20 97 01 02   email ipatrickgc@gmail.co mIntroduction:  Despite the universal recognition of unsafe abortion as a major public health  problem, very little research has been conducted to document its precipitating factors in Burkina  Faso.",Non-OADS,/arxiv_data1/oa_pdf/80/8f/ijwh-6-565.PMC4045174.pdf
"Available from: http://reproductiverights.org/ fr/document/les-faits-lois-relatives-%C3%A0-lavortement-%C3%A0- travers-le-mond e. Accessed March  29, 2014.",Non-OADS,/arxiv_data1/oa_pdf/80/8f/ijwh-6-565.PMC4045174.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/80/8f/ijwh-6-565.PMC4045174.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/8f/ijwh-6-565.PMC4045174.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 573–583International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  573Study Protocolopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJWH.S5843 8rationale, design, and cohort enrolment   of a prospective observational study of the clinical  performance of the new contraceptive implant  (Femplant) in Pakistan Syed Khurram Azmat1 Waqas Hameed1 Anja lendvay2 Babar tasneem Shaikh3 Ghulam Mustafa1 Muhammad Ahmed  Siddiqui1 Sajid Brohi1 Asif Karim1 Muhammad Ishaque1 Wajahat Hussain1 Mohsina Bilgrami1 Paul J Feldblum2 1research, Monitoring and Evaluation  department, Marie Stopes Society,   Karachi, Pakistan; 2FHI 360, durham,   Nc, uSA; 3Health Services Academy,   Islamabad, Pakistan correspondence: Syed Khurram Azmat   research, Monitoring and Evaluation   department, Marie Stopes Society,   21c commercial Area,   old Sunset Boulevard, dHA-2, Karachi,   Sindh 75300, Pakistan   tel +92 21 3538 9151   Fax +92 21 3580 3262   Email khurram.azmat@mariestopespk.or gIntroduction:  The use of hormonal implants has gained positive traction in family planning  programs in recent times.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
The study is also archived at http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available from: http://www.who.int/ reproductivehealth/publications/  family_planning/9789241563888/e n.  Accessed May 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available  from: http://www.who.int/reproductivehealth/publications/ family_ planning/9241562846index/e n. Accessed April 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available from: http://www.un.org/esa/population/publications/  contraceptive2011/contraceptive2011.ht m. Accessed June 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available from: http://www.acquireproject.org/ fileadmin/ user_upload/ACQUIRE/Publications/Ho rmonal-Impl ants- 2Pag er-final.,OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available from: http://www.guttmacher.org/pubs/AIU-2012-estimates.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available  from: http://measuredhs.com/pubs/pdf/AS28/AS28.pd f. Accessed  March 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available  from: http://www.unfpa.org/webdav/site/global/shared/documents/ publications/2012/Trends_in_maternal_mortality_A4-1.pd f. Accessed  March 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available from: http://www.savethechildren.org.uk/sites/default/ files/images/State_of_World_Mothers_2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available from: http://www.unfpa.org/webdav/site/ global/shared/factsheets/srh/EN-SRH%20fact%20sheet-LifeandDeath.,OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
"Available from: http://www.womendeliver.org/assets/UNFPA%20 MH%20fact%20sheet.pd f. Accessed April 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available from: http://www.gates - foundation.org/Media-Center/Press-Releases/2013/02/Partnership- Reduces-Cost-Of-Bayers-Reversible-Contraceptive-Implant.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
Available  from: http://press.healthcare.bayer.com/en/press/news-details-page.,Non-OADS,/arxiv_data1/oa_pdf/ab/da/ijwh-6-573.PMC4045175.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 555–564International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  555REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S4624 7Brachytherapy in the treatment of cervical   cancer: a review Robyn Banerjee1 Mitchell Kamrava2 1Department of Radiation Oncology,   T om Baker Cancer Centre, Calgary,   Alberta, Canada; 2Department of  Radiation Oncology, University of  California Los Angeles, Los Angeles,   CA, USA Correspondence: Mitchell Kamrava   200 UCLA Medical Plaza Suite B265,   Los Angeles, CA 90095, USA   Tel +1 310 825 9775   Email mkamrava@mednet.ucla.ed uAbstract:  Dramatic advances have been made in brachytherapy for cervical cancer.",Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
Available from: http://www.nccn.or g.  7.,Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
Available from: http://www.americanbrachytherapy.org/ guidelines/index.cf m.  53.,Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/ac/ijwh-6-555.PMC4045176.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813002410 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/20/bc/S0950268813002410a.PMC4045178.pdf
All statistical analyses were performed using R (packages Epicalcand EpiR; http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/20/bc/S0950268813002410a.PMC4045178.pdf
Maps were produced using QuantumGIS v. 1·7·4 (http://qgis.osgeo.org).,OADS,/arxiv_data1/oa_pdf/20/bc/S0950268813002410a.PMC4045178.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813002410.,Non-OADS,/arxiv_data1/oa_pdf/20/bc/S0950268813002410a.PMC4045178.pdf
"Washington, DC: Center for DiseaseDynamics, Economics and Policy, 2010 (http://www.cddep.org/sites/cddep.org/ ﬁles/publication_ ﬁles/ VN_Report_web_1.pdf).",Non-OADS,/arxiv_data1/oa_pdf/20/bc/S0950268813002410a.PMC4045178.pdf
Last accessed August 2012. https://secure.pharmacytimes.com/lessons/200510-03.asp .Evolution of Insulin Glargine 927,Non-OADS,/arxiv_data1/oa_pdf/e0/74/40265_2014_Article_226.PMC4045187.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813002124 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution licen ce <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/81/S0950268813002124a.PMC4045252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/02/mder-7-149.PMC4045256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2014:7 149–156Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  149REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S4547 2Critical evaluation of stents in the peripheral  arterial disease of the superficial femoral artery –  focus on the paclitaxel eluting stent Jason Litsky1 Arijit Chanda2 Erik Stilp1 Alexandra Lansky1 Carlos Mena1 1Section of Cardiovascular Medicine,   Department of internal Medicine,   Yale University School of Medicine,   New Haven, CT, USA; 2Section of  Cardiology, Department of Internal  Medicine, Bridgeport Hospital,   Bridgeport, CT, USA Correspondence: Jason Litsky   Yale University School of Medicine,   Fitkin Memorial Pavilion, 789 Howard  Avenue 3rd floor, New Haven,   CT 06519, USA   Tel +1 215 380 3389   Fax +1 203 483 8314   Email jason.litsky@yale,ed u Abstract:  The endovascular management of obstructive disease of the superficial femoral artery  (SFA) is challenging due to unique anatomical and biomechanical forces.",Non-OADS,/arxiv_data1/oa_pdf/c8/02/mder-7-149.PMC4045256.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/c8/02/mder-7-149.PMC4045256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/13/rmhp-7-105.PMC4045257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 105–112Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  105ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/RMHP .S6281 5Posthospital follow-up visits and  30-day  readmission rates in chronic obstructive  pulmonary disease salman s Fidahussein1 ivana T croghan2 stephen s cha3 David l Klocke4 1Department of Pulmonary and  critical care Medicine, norwalk  Hospital, norwalk, cT,   2Department of Medicine clinical  Research Office,  3Department of  Health sciences Research,  4Division  of Hospital internal Medicine,   Department of Medicine,    Mayo clinic, Rochester,    Mn, Usa correspondence: ivana T croghan   Department of Medicine clinical  Research Office, Mayo Clinic,   200 First street southwest,   Rochester, Mn  55905, Usa   Tel +1 507 266 1944  Fax +1 507 266 7900  email croghan.ivana@mayo.ed uPurpose:  To examine the effect of a follow-up visit with a primary care physician and/or  pulmonologist within the first  30 days of hospital discharge on readmissions, emergency  department (ED) visits, and mortality.",Non-OADS,/arxiv_data1/oa_pdf/ac/13/rmhp-7-105.PMC4045257.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/ac/13/rmhp-7-105.PMC4045257.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/13/rmhp-7-105.PMC4045257.pdf
Available from: http://www.medpac.gov/transcripts/1215162011.,OADS,/arxiv_data1/oa_pdf/ac/13/rmhp-7-105.PMC4045257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/c6/ott-7-853.PMC4045258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 853–863OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  853Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6088 8Clinical significance of promoter region  hypermethylation of microRNA-148a in  gastrointestinal cancers Jingxu sun1,* Y ongxi song1,* Zhenning Wang1 guoli Wang2 Peng gao1 Xiaowan chen1 Zhaohua gao1 huimian Xu1 1Department of Surgical Oncology  and general surgery, First hospital  of China Medical University,   Shenyang, People’s Republic of China;   2Department of Biochemistry and  Molecular Biology, China Medical  University, Shenyang, People’s  Republic of China *These authors contributed equally to  this work correspondence: Zhenning Wang   Department of Surgical Oncology,  First Affiliated Hospital, China Medical  University, North Nanjing Street 155,  shenyang 110001, People’s   Republic of China   Tel +86 24 8328 3556  email josieon826@sina.c nBackground:  MicroRNAs are associated with tumor genesis and progression in various  carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/f0/c6/ott-7-853.PMC4045258.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/c6/ott-7-853.PMC4045258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/c6/ott-7-853.PMC4045258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 217–225Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  217Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5846 1sensory impairments in community health care:  a descriptive study of hearing and vision among  elderly norwegians living at home gro gade Haanes1 Marit Kirkevold2 gunnar Horgen1 Dag Hofoss2 grethe eilertsen1 1Buskerud and Vestfold University  college, Kongsberg, norway;   2University of Oslo, Oslo, norway correspondence: gro gade Haanes   Buskerud and Vestfold University  college, Department of Health sciences,  Box 7053, n-3007 Drammen, norway   Tel +47 93437662   Fax +47 32206410   email gro.gade.haanes@hbv.n oBackground:  Hearing and vision impairments increase with age and are common risk factors  for functional decline reduced social participation and withdrawal.",Non-OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
"Available from: http://norlag.nova.no/asset/4363/1/4363_1.pd f.  Accessed: September 1, 2014.",OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
"Available from: http://www.who.int/healthinfo/ statistics/bod_hearingloss.pd f. Accessed: February  11, 2014.",OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
"Available from: https://extranet.who.int/iris/restricted/bitstream/10665 /41003/1/9241541261_eng.pd f. Accessed February 12, 2014.",OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ed/2a/jmdh-7-217.PMC4045259.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/2a/jmdh-7-227.PMC4045260.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 227–230Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  227SHort reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JMDH.S6060 4overcoming obstacles to establish a  multidisciplinary team approach to hepatobiliary  diseases: a working model in a Caribbean setting Shamir o Cawich1 peter B Johnson2 Sundeep Shah2 patrick roberts2 Milton Arthurs2 trevor Murphy2 Kimon o Bonadie2 Ivor W Crandon1 Hyacinth e Harding1 Mohammed Abu Hilal3 Neil W pearce3 1Department of Clinical Surgical  Sciences, University of the West  Indies, St Augustine Campus, trinidad  and tobago;  2Faculty of Medical  Sciences, University of the West  Indies, Mona Campus, Kingston,   Jamaica;  3University Surgical Unit,   Southampton General Hospital,   Southampton, United Kingdom Correspondence: Shamir o Cawich   Department of Clinical Surgical Sciences,  University of the West Indies, St  Augustine Campus, trinidad and tobago   tel +1 868 798 9627;   +1 868 315 7414  email socawich@hotmail.co mIntroduction:  By providing a structured forum to exchange information and ideas,  multidisciplinary team meetings improve working relationships, expedite investigations, promote  evidence-based treatment, and ultimately improve clinical outcomes.",Non-OADS,/arxiv_data1/oa_pdf/8c/2a/jmdh-7-227.PMC4045260.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/8c/2a/jmdh-7-227.PMC4045260.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/2a/jmdh-7-227.PMC4045260.pdf
Available from: http://www.dhcarenetworks.,OADS,/arxiv_data1/oa_pdf/8c/2a/jmdh-7-227.PMC4045260.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 231–237Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  231Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5865 6australian physiotherapists and their engagement  with people with chronic pain: do their emotional  responses affect practice?,Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
"Available from:  http://www.iasp-pain.org/files/Content/NavigationMenu/Advocacy/ International PainSummit/Australia_2010PainStrategy.pd f. Accessed  May 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
Available from: http://www0.health.,Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
"Available  from: http://www.inter-disciplinary.net/wp-content/uploads/2010/10/ pain2010ever11007102.pd f. Accessed May 15, 2014.",Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
"Available from: http://www.csp.org.uk/news/2012/10/18/phys - iotherapy-2012-physios-need-adopt-new-paradig m. Accessed May  16,  2014.",Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/af/d8/jmdh-7-231.PMC4045261.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/71/98/ndt-10-971.PMC4045262.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 971–975Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  971OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5960 0epileptic and cognitive changes in children   with cerebral palsy: an egyptian study hamdy N el-Tallawy Wafaa M a Farghaly ghaydaa a shehata reda Badry Tarek a rageh Department of Neurology, assiut  University hospitals, assiut, egypt correspondence: ghaydaa a shehata   Neurology and Psychiatry Department,   assiut University hospitals, assiut,   71111 egypt   Tel +20 088 229 7075  Fax +20 088 233 3327  email ghaydaa83@yahoo.co mBackground:  Cerebral palsy (CP) is the most frequent cause of motor handicap among  children.",Non-OADS,/arxiv_data1/oa_pdf/71/98/ndt-10-971.PMC4045262.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/71/98/ndt-10-971.PMC4045262.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/98/ndt-10-971.PMC4045262.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 841–852OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  841Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3412 4Critical appraisal of the role of gefitinib in the  management of locally advanced or metastatic  non-small cell lung cancer Ying Yuan Xiao-Fen Li Jia-Qi Chen Cai-Xia Dong Shan-Shan weng Jian-Jin Huang Department of Medical Oncology, the  Second Affiliated Hospital, Zhejiang  University School of Medicine,   Hangzhou, People’s Republic of China Correspondence: Jian-Jin Huang   Department of Medical Oncology,   the Second Affiliated Hospital,   Zhejiang University School of Medicine,   88 Jie-fang Road, Hangzhou, Zhejiang,  310009, People’s Republic of China   email huangjianjin18@gmail.co mAbstract:  Past studies have demonstrated that epidermal growth factor receptor (EGFR)  tyrosine kinase inhibitors can significantly improve clinical outcomes in patients with locally  advanced or metastatic non-small cell lung cancer (NSCLC) and sensitive EGFR  gene mutations.",Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
Available from:  http://globocan.iarc.fr/Pages/fact_sheets_population.aspx /.,Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
"Available from: http://www.merckmanuals.com/professional/ pulmonary_disorders/tumors_of_the_lungs/lung_carcinoma.htm l.  Accessed February 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/d1/ott-7-841.PMC4045263.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/vhrm-10-319.PMC4045264.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 319–326Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  319ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6403 8a double-blind, randomized trial, including  frequent patient–physician contacts and Ramadan- focused advice, assessing vildagliptin and gliclazide  in patients with type  2 diabetes fasting during  Ramadan: the sTeaDF asT study Mohamed Hassanein1 Khalifa abdallah2 anja schweizer3 1Betsi cadwaladr University Health  Board, Wales, United Kingdom;   2clinical Research center, alexandria  University Hospital, alexandria, egypt;   3global Medical affairs, novartis  Pharma ag, Basel, switzerland correspondence: Mohamed Hassanein   Betsi cadwaladr University Health Board,  Rhyl, n Wales, ll18  5UJ, United Kingdom   Tel +971 5566 76217  email mhassanein148@hotmail.co mBackground:  Several observational studies were conducted with vildagliptin in patients with  type 2 diabetes mellitus (T2DM) fasting during Ramadan, showing significantly lower incidences of  hypoglycemia with vildagliptin versus sulfonylureas, including gliclazide.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/vhrm-10-319.PMC4045264.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/bc/a9/vhrm-10-319.PMC4045264.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/a9/vhrm-10-319.PMC4045264.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/12/jpr-7-277.PMC4045265.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2014:7 277–290Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  277Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S4700 5Pain control following inguinal herniorrhaphy:  current perspectives Martin F Bjurstrom1,* Andrea L Nicol2,* Parviz K Amid3 David C Chen3 1Department of Anesthesiology,   UCLA, Los Angeles, CA, USA;   2Department of Anesthesiology,   University of Kansas, Kansas City,   KS, USA;  3Department of Surgery,   Lichtenstein Amid Hernia Clinic at  UCLA, UCLA, Los Angeles, CA, USA *These authors contributed equally   to this work Correspondence: David C Chen   Lichtenstein Amid Hernia Clinic at   UCLA,  1304 15th Street, Suite  102,   Santa Monica, CA  90404, USA   Tel +1 310 319 4080  email dcchen@mednet.ucla.ed uAbstract:  Inguinal hernia repair is one of the most common surgeries performed worldwide.",Non-OADS,/arxiv_data1/oa_pdf/5b/12/jpr-7-277.PMC4045265.pdf
"Relevant ongoing trials were  searched using national and international trial registers  (http://clinicaltrials.go v, https://www.clinicaltrialsregister.",OADS,/arxiv_data1/oa_pdf/5b/12/jpr-7-277.PMC4045265.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/5b/12/jpr-7-277.PMC4045265.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/12/jpr-7-277.PMC4045265.pdf
"EMBO J 12:1929 – 1936, http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/44/3a/10637_2013_Article_41.PMC4045313.pdf
"J Biol Chem 269:20209 –20212, http://www.jbc.org/content/269/32/ 20209.long 39.",Non-OADS,/arxiv_data1/oa_pdf/44/3a/10637_2013_Article_41.PMC4045313.pdf
"1 1      http://www.medsci.org  721  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  721-725.  doi: 10.7150/ ijms.8718   Research Paper   Risk F actors f or Long -term Outcome o f Drug-eluting  Stenting in  Adults with  Early-onset Coronary A rtery  Disease   Guipeng An1,2, Zhongqi Du1,2, Xiao Meng1,2, Tao Guo1,2, Guishuang Li1,2, Yuguo Chen1,2, Jifu Li1,2,  Fengshuang An1,2, Yun Zhang1,2, Wenjing Li3, Cheng Zhang1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
11     http://www.medsci.org  722  left main coronary disease  [2].,Non-OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
11     http://www.medsci.org  723  factors for cases and controls is  in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
"11     http://www.medsci.org  724  terval 0.86–3.14, p =  0.004, respectively; Table 5 ), after  adjusting  for age, gender, CAD extent , smoking st a- tus, BMI, hypertension  and hypercholesterolemia  at  baseline .",Non-OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
11     http://www.medsci.org  725  population was  small .,OADS,/arxiv_data1/oa_pdf/5b/e7/ijmsv11p0721.PMC4045791.pdf
"11       http://www.medsci.org  726  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  726-731.  doi: 10.7150/ ijms.8590   Research Paper   Polymorphism of Nrf2, an Antioxidative  Gene, is  Associated with Blood Pressure  and Cardiovascular  Mortality in Hemodialysis Patients   Yasuhiko Shimoyama1, Yoko Mitsuda2,Yoshinari Tsuruta3, Nobuyuki Hamajima4, Toshimitsu Niwa1,5  1.",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
11     http://www.medsci.org  727  Nrf2 also contributes to neuro- protection.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
"11     http://www.medsci.org  728  lows; 282, 113 bp for CC genotype, 282, 205, 113 bp for  CA genotype, and 282, 205 bp for AA geno type.",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
11       http://www.medsci.org  729  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
"11       http://www.medsci.org  730  Survival Analysis of Nrf2 Gene SNPs   Figure 1 shows estimates of survival by the r e- cessive model of rs35652124 genotype (A: all -cause, B:  cardiovascular).",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
"11     http://www.medsci.org  731  lial-independent manner, suggesting an important  role of Nrf2 in the regulation of vascular function in  humans [ 16].",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv11p0726.PMC4045792.pdf
"1 1      http://www.medsci.org  732  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  732-741.  doi: 10.7150/ ijms.7768   Review  Paratyphoid Fever: Splicing the Global Analyses   Cindy Shuan Ju Teh1, Kek Heng Chua2, Kwai Lin Thong3  1.",Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
"11     http://www.medsci.org  733  The disproportionate increase in the numbers of S.  Paratyphi A cases may be due to the vaccine effect  (Ty21a and Vi vaccines), which only protects ind i- viduals from S. Typhi infection (5 , 6) and also the i n- appropriate  preventive strategies against S. Paratyphi  A.",Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
"11     http://www.medsci.org  734  More recently, Liang et al.",OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
11     http://www.medsci.org  735  lation of S .,Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
11     http://www.medsci.org  736  Paratyphi A infections were detected during the p e- riod January –June 2011 and the patients were pr e- dominantly associated with travels to the Indian  subcontinent (57).,Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
"11     http://www.medsci.org  737  Basically, paratyphoid fever has three clinical  stages: an early stage marked by hi gh fever; a toxic  stage with abdominal pain and intestinal symptoms,  and a long period of recovery stage of fever or defer- vescence.",Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
"11     http://www.medsci.org  738  insensitive because of cross -reactivity with other ba c- teria which can also react with the antigens (91, 92).",Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
11     http://www.medsci.org  739  Roland et al.,OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
11     http://www.medsci.org  740  39.,Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
11     http://www.medsci.org  741  91.,Non-OADS,/arxiv_data1/oa_pdf/c7/19/ijmsv11p0732.PMC4045793.pdf
"1 1      http://www.medsci.org  742  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  742-747.  doi: 10.7150/ ijms.7167   Short Research Communication   Cyanidin 3 -O-Glucoside Reduces Helicobacter pylori  VacA- Induced  Cell Death of Gastric KATO III Cells  through Inhibition of the SecA Pathway  Sa-Hyun Kim1*, Hyunjun Woo2*, Min Park2, Ki-Jong Rhee2, Cheol Moon1, Dongsup Lee3, Woo Duck Seo4  and Jong Bae Kim2  1.",Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
This is an ope n-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
"11     http://www.medsci.org  743  with Sec protein in T5aSS3, 15, 18 .",Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
"11     http://www.medsci.org  744  MTT assay   Cell viability was measured by a quantitative  colorimetric assay with 3 -[4,5-dimethylthiazol -  2-yl]-2,5-diphenyltetrazolium bromide (MTT).",Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
1 1      http://www.medsci.org  745  SecA synthesis is inhibited by cyanidin  3-O-glucoside treatment in a dose -dependnet  manner   In our previous report we showed that C3G i n- hibited secA transcription21.,Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
11     http://www.medsci.org  746    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
11     http://www.medsci.org  747  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/49/4b/ijmsv11p0742.PMC4045794.pdf
"11       http://www.medsci.org  748  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  748-753.  doi: 10.7150/ ijms.8770   Research Paper   A Novel Catechol -O-Methyltransferase  Variant  Associated with Human Disc Degeneration   Helen E. Gruber1, Wei Sha 2,3, Cory R. Brouwer 2,3, Nury Steuerwald 4, Gretchen L. Hoelscher1, and  Edward N. Jr.  Hanley1   1.",Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
"11     http://www.medsci.org  749  phisms which are associated with human intervert e- bral disc degeneration, and several recent reviews  have provi ded updates and overviews [5-7].",Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
11     http://www.medsci.org  750  zygous genotype (12) to increase sample size.,Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
11     http://www.medsci.org  751  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
"11     http://www.medsci.org  752  pression of COMT in more degenerated (grades IV  and V) discs vs. less degenerated discs (grades I -III) (p  = 0.002), and also in surgical compared to control human discs (p = 0.035) [19].",Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
11     http://www.medsci.org  753  ical relevance of low back pain and the need for i m- proved understanding of the fundamental basis of  low back pain.,Non-OADS,/arxiv_data1/oa_pdf/3f/8f/ijmsv11p0748.PMC4045795.pdf
"1 1      http://www.medsci.org  754  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(7):  754-757.  doi: 10.7150/ ijms.8059   Research Paper   Cyclin A1 Is Expressed in Mouse Ovary  Hongquan Wei1, Yuanhong Li2, Chen Zhao1, Xuejun Jiang1, Hongduo Chen2, Ming -Fei Lang3,  Jing Sun1,4   1.",Non-OADS,/arxiv_data1/oa_pdf/b9/65/ijmsv11p0754.PMC4045796.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b9/65/ijmsv11p0754.PMC4045796.pdf
11     http://www.medsci.org  755  level and the protein level cyclin A1 was detected in  mouse ovary/oocyte.,Non-OADS,/arxiv_data1/oa_pdf/b9/65/ijmsv11p0754.PMC4045796.pdf
11     http://www.medsci.org  756    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/b9/65/ijmsv11p0754.PMC4045796.pdf
"11     http://www.medsci.org  757  another,  though not completely equivalent.",Non-OADS,/arxiv_data1/oa_pdf/b9/65/ijmsv11p0754.PMC4045796.pdf
This study wasregistered on the UK Clinical Research Network Portfolio Database (http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=14254 ) and International Standard Randomised Controlled Trial NumberRegister ( http://www.controlled-trials.com/ISRCTN85697880 )p r i o rt o data collection.,OADS,/arxiv_data1/oa_pdf/84/59/330_2014_Article_3187.PMC4046085.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/70/a1/srep05177.PMC4046124.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5177 | DOI: 10.1038/srep05177 9",Non-OADS,/arxiv_data1/oa_pdf/70/a1/srep05177.PMC4046124.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/d6/srep05188.PMC4046125.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5188 | DOI: 10.1038/srep05188 8",Non-OADS,/arxiv_data1/oa_pdf/00/d6/srep05188.PMC4046125.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/64/srep05179.PMC4046126.pdf
